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ABSTRACT
ADVANCED ANALYSIS OF COMPOUNDS OF TOXICOLOGICAL IMPORTANCE
BY ICE CONCENTRATION LINKED WITH EXTRACTIVE STIRRER (ICECLES)
GC-MS AND RP-HPLC-ESI-MS-MS

JOSEPH K. DZISAM

2019

Cyanide and nitrosoamines (NAs) are ubiquitous compounds, found in our food
and water, either by natural process or through man-made activities. The toxicity of
cyanide is exerted by its ability to inhibit metalloenzymes such as cytochrome c oxidase,
causing concomitant cascades of biochemical effects such as lactic acidosis, inhibition of
ATP production, respiratory seizure, and potential death. Nitrosoamines, on the other
hand, undergo biotransformation (metabolic activation in cytochrome P450) in the body
to produce unstable intermediates that alkylate DNA, causing mutations, and leading to
carcinogenesis. In order to further the advancement of a promising cyanide, cobinamide
(Cbi), an LC-MS-MS method was developed to analyze cyanide-complex Cbi, while an
ICECLES-GC-EI-MS procedure was developed to detect nitrosodipropylamine (NDPA)
at low concentrations in drinking water via a flexible, facile, relative easy performed, and
green method.
Cbi has shown promise as a therapeutic for cyanide poisoning. While current
analysis techniques only measure total Cbi, methods to elucidate the behavior of cyanidebound Cbi, total Cbi, and available Cbi (i.e., the difference between cyanoCbi and total
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Cbi) would be valuable for biomedical and pharmacokinetic studies. Therefore, a method
was developed for the analysis of cyanoCbi in plasma via liquid chromatography-tandem
mass spectrometry (LC-MS-MS). Plasma samples were prepared by denaturing proteins
with 10% ammonium hydroxide in acetonitrile. The resulting mixture was centrifuged,
and the supernatant was removed, dried, and reconstituted. CyanoCbi was then analyzed
via LC-MS-MS. The limit of detection was 0.2 µM, and the linear range was between 1200 µM. The accuracy was 100±17% and the precision, measured by relative standard
deviation (%RSD), was ≤18.5%. Carryover, a severe problem when analyzing Cbi via
liquid chromatography, was eliminated using a polymeric-based stationary phase (PLRPS) and a controlled washing protocol. The method allowed evaluation of the cyanidebound and ‘available’ Cbi from treated animals and, when paired with a method for total
Cbi analysis. This method allowed for estimation of Cbi utilization when treating cyanide
poisoning and verified for the first time, the hypothesized mechanism of treatment of
cyanide poisoning by Cbi (direct binding of cyanide).
To overcome the challenges associated with the analysis of NAs at ultratrace
levels (i.e., difficult extraction protocols, laborious sample preparation techniques, and
requirement for sophisticated/expensive instrumentation), an advanced sample
preparation technique, ICE Concentration Linked with Extractive Stirrer (ICECLES),
coupled to an inexpensive low-resolution gas-chromatography electron ionization massspectrometry instrument was used to analyze NDPA (MRL = 7 ng/L (ppt)). An LOD of
0.2 ng/L was obtained for NDPA, along with linear range of 2 to 50 ng/L was produced
(using NDPA-d14 internal standard). Both inter- and intraassay precision were ≤13%RSD,
while the method accuracy was 100±17.5%. The ICECLES method was applied to screen

xviii
for possible NA contamination in selected drinking water sources. The concentration of
NDPA in one drinking water source was 2.38±0.34 ng/L. Moreover, NDPA was detected
in the two other municipalities tested (i.e., concentrations > 0.2 ng/L), but it was not
quantifiable.
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CHAPTER 1. INTRODUCTION
1.1.Overall Significance and objectives
Cyanide is a toxic chemical that may be introduced into living organisms by
natural process and/or anthropogenic uses [1]. Potential sources of cyanide include
edible and non-edible plants (such as apricots, stone seeds, and cassava), cigarette
smoke, and occupational exposure from industrial operations such as plastic
processing and paint manufacturing. Over one million tons of cyanide are used for
industrial purposes, such as being the lixiviant of choice in the mining industry [2].
Cyanide has been used as a chemical warfare agent for terrorist purposes, and for
criminal purposes. Cyanide causes toxicity in living organisms by inhibiting
cytochrome c oxidase in the mitochondria, resulting in impairment of oxidative
phosphorylation, and subsequently leading to progressive lactic acidosis, histotoxic
hypoxia, cytotoxic anoxia, and ultimately, death [3-5]. Cobinamide (Cbi) is a novel
cyanide antidote proposed to be superior to available FDA-approved therapeutics.
However, current methods for analyzing Cbi in biological systems lack the ability to
measure the available Cbi, which is imperative to understand the pharmacokinetic
behavior in order to approve Cbi as a cyanide antidote. Therefore, the objective of our
work was to create a method for the analysis of Cyano Cbi. This method would pair
with a method to detect the total Cbi previously developed in our lab to allow
quantification of the available Cbi [6].
Nitrosoamines (NAs) are potent mutagens, carcinogens, and teratogens. NAs
exert their toxicity by a series of metabolic activation in cytochrome P450 through
hydroxylation of the α-C-atom of the N-N=O group of NAs. The α-hydroxy
nitrosamine is highly unstable, and can easily degrade to form formaldehyde and
methyldiazohydroxyde. The fate of these compounds leads to the production of
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diazonium ion or a carbenium intermediate, which both have the propensity to
alkylate DNA, RNA and proteins, leading to mutations, and ultimately carcinogenesis
[7-11]. NAs are associated with food and soils, and are typically, together with their
precursors, found in agro-chemicals, tanned leather products, solvents, cutting fluids,
drugs, plastics, rubber additives, detergents, and ground or drinking water. Drinking
water is perhaps one of the most concerning routes for NA exposure [12]. NAs are
formed during the water purification process as a disinfection byproduct (DBP)
during chlorination and chloramination [13-16]. Disinfectants, such as chlorine,
ozone, chlorine dioxide or chloramines, react with naturally occurring organic matter
or anthropogenic contaminants to produce NAs [13-19]. The presence of NAs in
drinking water can also result from contamination by industrial and/or agricultural
sources [13, 20], or from anion exchange resins [21] (i.e., anion exchange resins used
to remove anionic contaminants can produce higher NA levels in finished products).
The US EPA estimates a 10-6 cancer risk of 0.2–20 ng/L for most nitrosoamines in
drinking water and unregulated contaminant monitoring minimum reporting levels
(UCMRL) range from 2 to 7 ng/L. Analysis of NAs at these concentrations is
extremely difficult, requiring sophisticated instrumentation and laborious sample
preparation techniques. Therefore, there is the need to develop a simple method that is
capable of analyzing one or more NAs as a probe for indicating the presence of NAs
(i.e., NAs are not typically found in isolation), to mitigate the cancer risk among the
populace across the US and beyond. The specific objective of this work was to
develop an ICE Concentration Linked with Extractive Stirrer (ICECLES)-gas
chromatography (GC-MS) analysis method to detect nitrosodipropylamine, NDPA,
(MRL = 7 ng/L) as a probe for NA contamination.
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Chapter 2 reports the determination of available Cbi via liquid chromatographytandem mass spectrometry (LC-MS-MS). Chapter 3 details the ICECLES-GC-MS, a
novel method that has the ability to detect concentrations of NDPA below the EPA
minimum reporting limits (MRL) levels without using expensive and sophisticated
instrumentation, such as high resolution GC-MS or GC-MS-MS or LC-MS-MS.
Chapter 4 details the broader impacts and benefits of this study as well as conclusions
and future directions.
1.2.History, Uses and Exposure to Cyanide
Cyanide was first isolated from Prussian blue dye in 1786, and later extracted
from almonds around 1800. In about 1815, Gay-Lussac identified cyanide as a
colorless and poisonous gas having a characteristic almond-like smell/flavor. He
named it cyanogen.
1.2.1. Criminal Uses of Cyanide
Cyanide is a common chemical for suicides and homicides. The malicious use
of cyanide has been well-recorded. In November 18, 1978, about 913 members of
People’s Temple in Jonestown, Guyana, were murdered by Jim Jones after giving the
members a punch laced with cyanide [22]. Seven (7) people in September 29, 1982
were killed when cyanide was added into Tylenol capsules [1, 23]. This led to modern
“tamper-proof” packaging ubiquitous in the pharmaceutical industry. The murder of a
dry-cleaning owner, Urooj Khan, by cyanide occurred just a day after he won lottery
in July 20, 2012 [24, 25]. The killing of physician Dr. Autumn Klein in April 20,
2013 by her husband, Robert Ferrante [26], was perpetrated with a cyanide-laced
energy drink. Cyanide fishing, a practice whereby sub-lethal doses of cyanide are
used to stun fish for easy catch is also another illegal use of cyanide [1]. Some
planned but failed uses of cyanide for criminal purposes includes the purported use of
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cyanide in cloud bombing at the World Trade Center by Ramzi Yousef, the Philippine
Airlines Flight 434, the attempted poisoning of water supplies to the US embassy in
Morocco in 2002, and the planned of dispersing of cyanide gas through indoor
ventilation systems by alQaeda terrorists as reported by US Department of Homeland
Security in 2003 [27, 28]. In the 1995 Tokyo subway attack that caused over 5000
injuries and 12 deaths [1, 27], cyanide gas precursors were found in the subway
washrooms, where the perpetrators had intended to use both cyanide and sarin for the
attack [1, 29, 30].
1.2.2. Cyanide as a Chemical Warfare Agent
Chemical warfare agents are defined as any chemical substance whose toxic
properties are utilized to kill, injure or incapacitate an enemy in warfare and
associated military operations [31, 32]. CWAs are mostly synthetic chemicals that are
highly toxic, with fast rapid onset of action, and are generally imperceptible to the
senses [27]. Cyanide is a considered blood agent because its mode of action entails
prevention of normal oxygen utilization by the tissues [27, 31]. Hydrogen cyanide
(HCN) and cyanogen chloride (CNCl) [inclusively referred to as cyanide] are the
most common CWAs of the blood agent class, and were first used by the French as a
CWA in the battle of Somme in 1916 [28, 33]. Zyklon B gas (HCN) was used by the
Nazis during World War II to kill millions of innocent civilians [27, 28, 30]. Cyanide
was also used as a CWA during the Iran–Iraq war from 1983-1988 [28]
1.2.3. Industrial Uses of Cyanide
Worldwide, over 1 million tons of hydrogen cyanide are produced annually for
legitimate purposes and approximately 0.9 million tons of this are used in the United
States [1, 2]. Cyanide is mostly used in plastic manufacturing, photographic
developing, metallurgy, adhesives, computer electronics, fire retardants, cosmetics,
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some dyes, some pharmaceuticals, and in ship fumigation [1, 2, 34, 35]. Cyanide is
also used for metal mining (e.g., gold and silver ores), metal cleaning/polishing,
production of triazines for agricultural herbicides, production of adiponitrile for
nylon, and in making rocket propellant [2, 24, 34]. Other uses include the production
of methionine for animal feed supplements, and the production of chelating agents
such as nitrilotriacetate for water and waste water treatment [36, 37]. Some
derivatives of cyanide, such as sodium ferrocyanide and ferric ferrocyanide, are used
as road salts to serve as anticaking agents [36-38].
1.2.4. Potential Sources of Cyanide and Exposure
The sources of cyanide can be natural or anthropogenic [34]. Exposure of
cyanide in any form can occur through inhalation (such as smoke from cigarettes or
fires), ingestion of cyanogenic compounds (e.g., cassava, almonds, lima beans etc.),
dermal absorption (e.g., occupational hazards, i.e., coming into contact with cyanide
at the workplace and by parenteral administration (such as the administration of
sodium nitroprusside for vasodilation) [34, 39, 40].
1.2.4.1. Natural Sources of Cyanide
Cyanide is ubiquitous in nature and can be produced in certain plants, bacteria,
fungi, and algae [34, 41-43]. Most natural sources of cyanide emanate from
organocyanide complexes (i.e, organic compounds that has part of it as cyanide
functional group attached to a carbon atom by way of covalent bonding, e.g., such as
acetonitrile). Under normal environmental conditions, there are over 2650
cyanophoric plant species (of about 550 genera and 130 families) (Figure 1.1) to
produce cyanogenic glycosides and HCN as a natural defense mechanism (typically
against herbivory and pathogenic attack). Cyanogenesis may also occur when a plant
is damaged or stressed [43]. Most glucosidic cyanogens are produced naturally from
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amino acids (e.g., lotaustralin from isoleucine, linamarin from valine, amygdalin and
prunassin from phenylalanine, and dhurin from tyrosine) [42]. Some examples of
cyanogenic plants include plants with significant economic and commercial value
such as cassava, lima beans, corn, forage materials (e.g., alfalfa, sudan grasses, and
sorghum), stone fruits (e.g., apricots, apples, peaches), and horticultural plants (e.g.,
ornamental cherry and cherry laurel). Cassava, a common tropical staple food in most
African countries, contains about one-half the lethal dose of cyanide if consumed
daily [42], and it has been associated with the neurological disease known as Konzo
[44-51]. Cyanides are also produced by almost all fruit-bearing plants during ethylene
synthesis and nitrile metabolism [34, 43, 52]. Some nitriles can also be found in shale
oils, as plant growth hormones or as a product of cyanohydrins. Some species of
fungi, such as Clitocybe, Marasmius, Pholiota, Polyporus, and Tricholoma are
capable of undergoing fungal cyanogenesis to produce hydrogen cyanide. In fact, the
first production of cyanide by microbes was reported in Marasmius oreades by von
Lösecke in 1871 [42]. Other types of microbes that produce cyanide are some strains
of the bacteria pseudomonads and Chromobacterium violaceum, as well as the algae
Chlorella vulgaris [42, 43, 53, 54]. Also, HCN is present in the earth’s atmosphere,
and has been detected in the troposphere and the stratosphere [43].
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Figure 1. 1. Cyanogenesis in Plants [43].

1.2.4.2. Production of Cyanide
Cyanide in its various forms is directly produced or is used as a raw
material/precursor for the production of other compounds. An increasing amount of
HCN has been produced in the industry over recent years, as shown in Figure 1.2
[43]. Cyanide is produced by the Andrussow process (a three-step process where
ammonia, natural gas and air are reacted in the presence of platinum catalyst to form
HCN) or the Blausaure Methane Anlage (BMA) process (which involves the use of
ammonia and natural gas for the production of cyanide) [55]. HCN is very important
in industry because it is the main precursor for the manufacturing of methyl
adiponitrile, methacrylate for polymer manufacturing, cyanuric chlorides, chelating
agents, and sodium/potassium cyanide for hydrometallurgy of minerals [34, 55].
Apart from the sources listed above, cyanide can also be emitted from iron and steel
production, carbon black production, carbon fiber production, and petroleum refining
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[55]. The number of workers exposed to cyanide are estimated as follows: 4,005 to
hydrogen cyanide, 66,493 to sodium cyanide, 64,244 to potassium cyanide, 3,215 to
potassium silver cyanide, 3,606 to calcium cyanide, 22,339 to copper (I) cyanide, and
1,393 to cyanogen chloride [34]. An example of an occupational exposure was the
August 12, 2015 warehouse explosion in Tianjin, China [56-58], where an explosion
occurred in a warehouse containing cyanide, and 114 people were killed, 700 injured,
and 69 were declared missing [58].
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Figure 1. 2. HCN production from 1983 to 2001 [43].

1.2.4.3. Environmental Sources of Cyanide
Potential sources of cyanide in the environment are wide-ranging, and include
natural sources such as cyanogenic plants or anthropogenic sources, including
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discharges from industrial processes, cyanogenic drugs, laboratories, fires, chemical
warfare operations, and cigarette smoke.
It is estimated that cyanide emissions are about 44 million pounds/year. The
main source of cyanide is from car/automobile exhausts. Other cyanide sources
include chemical processing (e.g., methyl methacrylate, acrylonitrile, hydrogen
cyanide, and municipal waste incinerators), metabolic or biogenic processes from
microbes such as fungi and bacteria, and higher plants also release hydrogen cyanide
into the atmosphere. In addition, biomass burning contributes about 1-3 billion
pounds of cyanide/year in the form of hydrogen cyanide and acetonitrile according to
field measurements and modelling estimates [43].
A significant source of cyanide in water and soil is from accidental leaks from
heap leaching pads from the gold mining industry [43]. Examples include the release
of over 1 billion gallons of cyanide bearing tailings due to a dam failure in Guyana in
1995, 7 million gallons of cyanide from a storage pond to the Beaver Dam Wash in
Utah in 1995, and the over 250,000 gallons of cyanide solution from a heap pad in a
Gold Quarry Mine in Nevada, 1997 [43]. The release of cyanide into aquatic systems
may occur from discharges from point sources such as publicly owned treatment
works (POTWs), the organic chemical industry, and the iron and steel industry.
Nonpoint sources are mainly from agricultural, road runoff, and atmospheric fallout
[34, 59].
The largest sources of cyanide in soil are from landfills and anticaking agents.
Cyanide can also be released into the soil through natural biogenic processes of
bacteria, fungi, and cyanogenic plants as well as by way of decay of plant tissues from
the Brassica family [34].
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1.2.4.4. Iatrogenic Sources of Cyanide
Cyanide exposure can occur when taking sodium nitroprusside (SNP) as
antihypertensive drug for a prolonged period of time [39, 60-62]. Usually,
nitroprusside is administered intravenously to reduce peripheral blood pressure by
vasodilatation (by the release of nitric oxide, NO), and also to control bleeding during
surgery [63-66]. However, SNP contains about 44% cyanide by molecular weight,
which, can be released upon administration [39, 63, 67-69]. The liver enzyme
rhodanese is capable of converting cyanide to the innocuous thiocyanate. However,
toxicity may occur if the administration is prolonged or there is a defect in cyanide
metabolism, such as impaired renal function, thiosulfate deficiency, or rhodanase
deficiency [39]. The toxicity of sodium nitroprusside can be eliminated when other
therapeutics such as a sodium thiosulfate and or sodium nitrile are co-administered
[61, 63, 70]. Another Iatrogenic source of cyanide is from succinonitrile, a commonly
used drug in Europe, as an antidepressant [71] and laetrile, an anticancer drug [39, 7278].
1.3.Fate and Toxicity of Cyanide
Cyanide forms stable and reversible complexes with biologically active metal ions
in metalloenzymes (e.g., cytochrome c oxidase, peroxidase, nitrogenase, etc.), and
consequently inhibits the function of the enzymes. Furthermore, the cyanide can
inhibit the function of some non-metalloenzymes, such as ribulose diphosphate
carboxylase [71]. The main cause of cyanide toxicity is a result of binding cyanide
with cytochrome c oxidase a3 (the ferric iron atom), a terminal oxidase of the
mitochondria electron-transport chain (ETC), and consequently blocks oxidative
phosphorylation [79]. Cytochrome c oxidase is the primary source of energy
production in the form of ATP (Adenosine triphosphate). It facilitates a series of
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electron and proton transfer from O2 to produce water [34, 40, 80], as shown in Figure
1.3 [81]. NADH delivers electrons and protons initially to complex I, which in turn,
are transported throughout the electron-transport chain (ETC) via complex I through
IV. As the electrons are transferred, protons are sequentially pumped to the cytosolic
side of the inner membrane, creating an electrochemical gradient. The electrochemical
gradient generates a membrane potential that is harnessed by ATP-synthase to
produce ATP [40, 82]. The net reaction in the cytochrome c oxidase a3 (complex IV)
in transport of electrons and protons is shown in Equation 1.1 [82]. The transfer of
electrons to O2 is the terminal step for oxidative phosphorylation. When cyanide
interacts with cytochrome c oxidase a3, it binds with the trivalent iron in the enzyme,
and inhibits the activity of the enzyme complex, leading to anaerobic respiration 33
[34, 82]. To compensate, excess pyruvate is produced, but cannot be channeled
through the ETC [81-83]. This results in the production of excess lactic acid via
anaerobic metabolism, leading to metabolic acidosis, and decreased pH in the body.
The anaerobic metabolism may also lead to progressive histotoxic hypoxia, oxidative
stress (from production of excess reactive oxygen species, ROS), cytotoxic anoxia,
and cell death [5, 39, 40, 83-88].
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Figure 1. 3. Electron transfer mechanism and the generation of proton-motive force
required for oxidative phosphorylation to take place in the mitochondria. Four
protons, known as the ‘chemical protons’ (since they are ‘participants’ of the reaction)
are taken up from the matrix side to oxygen. At the same time, four additional protons
are transported from the matrix side into the cytosol (cytoplasm) to bring about the
electrochemical gradient that is required for the production of ATP through
bioenergetics-coupled reactions [82].

+
+
4𝐶𝑦𝑡𝑐𝑟𝑒𝑑 + 8𝐻𝑚𝑎𝑡𝑟𝑖𝑥
+ 𝑂2 → 4𝐶𝑦𝑡𝑐𝑜𝑥 + 2𝐻2 𝑂 + 4𝐻𝑐𝑦𝑡𝑜𝑝𝑙𝑎𝑠𝑚

(1.1)

In Equation 1.1, Cytcred and Cytcox, refers to the reduced and the oxidized
form of Cytochrome oxidase a3, respectively. A CN-bound cytochrome c oxidase
cannot be reduced, and cellular oxygen utilization is impaired. Consequently, aerobic
respiration is reduced or stopped [81, 84, 86].
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1.3.1. Absorption of Cyanide
The major route of cyanide absorption is through the gastrointestinal tract and
the respiratory system, with minimal dermal absorption [34, 40, 55, 84]. Cyanide is
absorbed readily in the gastrointestinal tract but the rate of absorption across the
gastrointestinal mucosa depends on a number of factors such as the pH of the gut, the
solubility and the form of cyanide [40]. Usually, small, neutral and non-ionized
compounds are readily absorbed by biological membranes. NaCN and KCN are easily
dissolvable, and can be absorbed in the stomach-post ingestion. Also acidic conditions
in the stomach enhance the absorption of hydrogen cyanide (pKa of 9.2 at 25 °C) [34,
40]. HCN is mostly absorbed after inhalation, where it instantly passes through the
alveolar epithelium of the lungs [34, 40].
1.3.2. Distribution of Cyanide
Once cyanide enters the body and is absorbed, it is distributed throughout the
body, with targeted tissues being those that have the highest oxygen demand (e.g.,
heart, brain, liver, kidney, stomach). The brain and the heart are the primary target
organs in acute cyanide intoxication, with characteristic symptoms, such as
convulsion, impaired respiratory activity, and cardiovascular difficulties. Also,
elevated cyanide levels can be measured in absorptive tissues, such as lungs (when
cyanide is exposed via inhaling) and stomach (when cyanide is orally ingested) [34,
40, 55]. Approximately 60% of absorbed cyanide binds to proteins, and has high
affinity for transition metals, such as iron and cobalt [84].
1.3.3. Acute Effects of Cyanide
Acute and subacute effects of low-level cyanide may result in lactic acidosis,
progressive anorexia, anxiety, weak and rapid pulse rate, nausea, and vertigo [34, 43,
71]. The symptoms progress to irregular heartbeats, cardiac arrhythmias, drop in body
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temperature, cyanosis of lips and face, and sometimes, frothy bloody saliva from
mouth, and death [34, 39, 71, 83]. For humans, inhalation of about 110 to 135 ppm of
cyanide may result in death within few hours, while an inhalation of about 220 to 270
ppm causes death in minutes [71].
1.3.4. Chronic Effects of Cyanide
Chronic effects of cyanide are systemic and can include neurological,
respiratory, cardiovascular, and hepatic disorders [34, 71]. Chronic cyanide exposure
leads to neuropathic and thyrotoxic disorders [52, 71].
Brain areas that control skeletal muscle activity (i.e basal ganglia, cerebellum),
memory (hypothalamus), and cognitive ability (cortex) are the most effected parts of
the central nervous system from cyanide poisoning [43]. Human neuropathies
associated with nonlethal chronic cyanide exposure of low cyanide levels includes
Nigerian nutritional neuropathy (tropical ataxic neuropathy, TAN), Konzo, tobacco
amblyopia, and Leber’s optical atrophy [34, 71, 89]. Neurological effects of cyanide
poisoning are mainly due to the blockage of mitochondrial cytochrome c oxidase
activity, leading to rapid biochemical changes in the brain, such as changes in ion
flux, neurotransmitter release (both excitatory and inhibitory), peroxide formation,
and decrease in the ATP/ADP ratio required for cellular calcium homeostasis [34, 43].
The cardiovascular system is an important site for cyanide toxicity [43].
Specific cardiovascular symptoms of cyanide exposures include hypotension,
supraventricular tachycardia, atrioventricular blocks, ventricular fibrillation, and
asystole [34, 39]. Cyanide toxicity also alters respiration due to inadequate cellular
oxygen utilization, leading to deficit in traditional global oxygen consumption/oxygen
saturation curve [78, 90]. Respiratory effects of cyanide toxicity include coughs, sore
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throat, nasal congestion, epistaxis, hemoptysis, dyspnea, apnea, decrease in
respiratory rate/hypoventilation, and asphyxia [34, 39].
1.4. Cyanide Antidotes
Cyanide has several antidotes that have different mechanisms of
action/pharmacokinetics, clinical effects, and risk-benefit profiles. Cyanide antidotes
include the Nithiodote (which contains sodium nitrile and sodium thiosulfate) and
Cyanokit (hydroxocobalamin). Dicobalt-ethylenediamine tetraacetic acid (dicobalt
Edetate) and 4-dimethylaminophenol (4-DMAP) are used to a lesser extent due to
their relatively significant contra-indications [6, 39, 84, 91-93].
1.4.1. Clinical Properties of Ideal Cyanide Antidotes
A cyanide antidote that meets the need of a victim in acute exposure of
cyanide should have some important properties, including 1) rapid onset of action, 2)
capable of neutralizing cyanide without interfering with cellular oxygen use or
transport, 3) conducive safety and tolerability profiles in pre-hospital settings and
emergency situations, 4) safe for use with victims with smoke inhalation, 5) not
harmful when administered to non-poisoned patients and 6) easy to administer,
especially in mass casualty situations [91, 93]. Table 1.1 [91] shows some cyanide
antidotes and their ability to satisfy these ideal qualities.
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Table 1. 1. Selected cyanide antidotes and their suitable qualities as cyanide antidotes
[91].

Quality

CAK

Na2S2O3
alone

4DMAP

Dicobalt
edetate

Cbl

Rapid onset of action

Yes

No

Yes

Yes

Yes

Neutralize CN without compromising
oxygen-carrying capacity

No

Yes

No

Yes

Yes

Tolerability and safety profile conducive
to prehospital use

No

Yes

No

No

Yes

Safe use in smoke-inhalation victims

No

Yes

No

No

Yes

Not harmful when administered to nonpatients

No

Yes

No

No

Yes

Easy to administer

No

Yes

Yes

Yes

Yes

1.5. 1.4.2. Mechanism and General Classes of Cyanide Antidotes
The current US FDA approved cyanide antidotes are sodium nitrite, sodium
thiosulfate, and hydroxocobalamin [6, 30, 35, 39, 56, 84, 91, 92, 94-96].
1.4.2.1. Methemoglobin generators
A methemoglobin generator, such as sodium nitrite, reverses cyanide
poisoning by interacting with hemoglobin (Hgb) to form the oxidized Hgb,
methemoglobin (MetHgb). CN has low affinity to Hgb but has relatively high affinity
to MetHgb. Consequently, CN reacts with MetHgb to form cyano-MetHgb complex
(Scheme 1.1), which can be facilely excreted via urine [84, 91, 92]. Although nitrite
activity is mainly attributed to the formation of MetHgb, recent studies suggest that
nitrite-mediated conversion of Hgb to MetHgb is too slow to account for cyanide
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antagonism [96]. It has been proposed recently that another mechanism of action
accounts for the nitrite’s antidotal activity; nitrites induce the generation of nitric
oxide, which subsequently displaces cyanide bound to the active site of cytochrome c
oxidase [84, 95-97], which restores the activity of cytochrome c oxidase. The
displaced CN may be scavenged by circulating MetHgb, or converted to SCN [84].
However, methemoglobenimia produced by nitrite reduces the oxygen saturation level
and transport. This is a serious condition for victims who are exposed to cyanide
through smoke inhalation, where the formation of carboxyhemoglobin occurs, in
addition to methemoglobenimia. As a result, administration of sodium nitrite is
followed by careful observation of victims’ oxygen level, and constant oxygenation.
Another disadvantage of sodium nitrite administration is that it requires intravenous
administration. Thus, the main challenges of sodium nitrite administration as a
cyanide antidote are its contra-indication exhibited by compromising oxygen
transport, and difficulty with mode of administration, requiring special skill for
administration [91].

NaNO2 + HgbO2

MetHgb

MetHgb + CN-CytC

CN-MetHgb + CytC

Scheme 1. 1. Sodium nitrite (NaNO2) helps in scavenging cyanide. Fe2+ in the
oxyhemoglobin is oxidize to Fe3+ in MetHgb. Formation of large amounts of Methgb
with its concomitant trivalent ferric iron has relatively high affinity for cyanide, and
so binds cyanide more than cytochrome c oxidase (CytC) [56, 98].

1.4.2.2. Sulfur Donors
Sulfur donor-based antidotes, such as sodium thiosulfate (Na2S2O3) detoxify
cyanide by first donating sulfur (S) to Rhodanese (Rh) to form S-Rh [92, 95]. The
sulfur-bound Rh then reacts with the CN to form SCN- (Scheme 1.2) [99], which is
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easily excreted in the urine. CytC Oxidase activity is restored in this process and
aerobic respiration resumes [39, 91, 92]. However, Rh is predominantly located in the
mitochondrial matrix of the liver and kidney but limited in the central nervous system
(brain) and heart, leaving these two important organs relatively unprotected [40, 56,
91, 92, 95]. In addition, Na2S2O3 has slow onset of action due to limited penetrability
through the mitochondrial membranes to the enzyme Rh. Furthermore, Na2S2O3
requires intravenous administration [6, 56, 60, 84, 92, 95].

Rh + SSO3Rh-S + CN-

k+1
k-1
k+3

Rh(SSO3-)

k+2

Rh-S + SO3-

SCN- + Rh

Scheme 1. 2. Rhodanese enzyme reaction with CN to produce SCN-. Mechanistically,
the reaction goes through a double replacement process to catalyze the detoxification
of cyanide by sulfuration [40, 99, 100]. The free enzyme (Rh) reacts with a sulfane
sulfur donor (e.g.,SSO3-) to cleave the S-S bond to form the persulfide-substituted
enzyme, Rh-SSO3-. The Rh-SSO3- then reacts with sulfur acceptor substrate (CN-) to
form the innocuous thiocyanate, SCN, and regenerates the enzyme, Rh [40, 99].

1.4.2.3. Direct Binding Agents
The only FDA-approved direct binding cyanide antidote is hydroxocobalamin
[84, 91, 92, 95, 101, 102] (Figure 1.4). Hydroxocobalmin (Cbl) is a hydroxylated
form of vitamin B 12 [40, 84]. Cyanide has a greater affinity to bind with Cbl than
cytochrome oxidase a3 [103]. Thus, Cbl directly reacts (non-enzymatically) with
cyanide to form the cyanohydroxocobalamin (CN-Cbl) (Scheme 1.3), which is renally
excreted [101]. Cbl is relatively safe because it does not interfere with oxygencarrying capacity of blood, it is not harmful when administered to non-poisoned
patients, and it is easy to administer for small number of casualties at the site of
exposure etc. [39, 40, 102, 104]). Even though Cbl is effective, large volumes are
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required via intravenous administration. Consequently, Cbl is not suitable in mass
casualty situations [40, 56, 84, 95].

Figure 1. 4. Chemical structure of hydroxocobalamin, with the nucleotide moiety,
dimethylbenzimidazole ribonucleotide, shown in blue color.

Cbl + CN-

CN-Cbl Complex

Scheme 1. 3. Reaction of hydroxocobalamin with cyanide, without the aid of
enzymes. Cbl binds cyanide molecule in a 1: 1 mole ratio [105, 106].

1.4.2.4. Combination Therapies
In the US, Nithiodote is the only FDA-approved combination therapy.
Nithiodote is typically administered by intravenous infusion, which is not practical
when trained personnel are absent and in mass casualty situations [35]. For effective
and efficient treatment during mass casualty scenarios, the best mode of
administration should be via intramuscular injection of the antidote by first
responders, usually from a prefilled autoinjector. For this situation to be feasible, the
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antidote needs to be stable in solution, sufficiently soluble to be administered in 1-3
mL doses, needs to be highly potent so that relatively small amount is administered,
and should be readily absorbed when administered intramuscularly [35, 94]. Sodium
nitrite and sodium thiosulfate are quite soluble in water, and stable under anaerobic
conditions, and are typically effective when administered intravenously. However,
current work by Bebarta et al. [94] shows that Nithiodote has some activity against
cyanide when administered by intramuscular injection.
When studying other combination therapies, Berbata et al. [107] showed that
hydroxocobalamin with sodium thiosulfate led to faster return to baseline mean
arterial pressure compared with administration of sodium nitrite with sodium
thiosulfate. There was no significant difference in mortality, serum acidosis, or serum
lactate for either of the antidote combinations. Hall and Rumack [108] reported that
hydroxocobalamin with sodium thiosulfate is an efficacious cyanide antidote with
little inherent toxicity.
1.4.3. Next Generation Cyanide Antidotes
Since the onset toxicity of cyanide is rapid, there is the need for antidotes that
are capable of being rapidly administered by minimally trained individuals, especially
in a mass exposure scenario. Therefore, the development of next generation antidotes,
which possess better therapeutic indices and efficacy, have a relatively easy mode of
administration (e.g., intramuscularly or orally), and are equally effective throughout
the body, is an important priority going forward. Currently, the most well-studied
next generation cyanide antidotes under investigation are cobinamide [6, 30, 35, 84,
93, 105, 109], sulfanegen (i.e., 3-mercaptopyruvate) [6, 84, 92, 95, 96, 105, 110], and
dimethyl trisulfide [56, 111-114]. Table 1.2 outlines some of these antidotes, each of
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which can be administered intramuscularly (IM) in mass casualty scenarios, and their
mode of action [84].
Table 1. 2. Novel Cyanide therapies in development for rapid IM in mass casualty
scenarios [84].
Novel
therapy

Mode of action

Older
analog

Cobinamide Direct binding agent

Cbl

Sulfanegen

Sulfur donor (leverages 3 mercaptopyruvate sulfur
transferase)

3-MP

DMTS

Sulfur donor (with/without Rhodanese enzyme)

NA

1.4.3.1.Cobinamide
Cobinamide is the penultimate precursor in the biosynthesis of cobalamin
(Cbl). Structurally, Cbi is similar to Cbl but Cbi lacks dimethylbenzimidazole
nucleotide tail moiety [6] that is coordinated to the cobalt atom in the lower axial
position of the Corrin ring (Figure 1.5). The lack of the dimethylbenzimidazole
ribonucleotide in Cbi makes it possible for it to have a second free binding site, and
prevents the trans site steric hindrance associated with the dimethylbenzimidazole
group [30, 79, 84, 109, 115-120]. Consequently, Cbi has relatively smaller mass [6],
and a mole of Cbi binds to two moles of cyanide (1 mole Cbl binds to only 1) with an
overall cyanide binding affinity of 1022 M−2 (1012 mol/L for Cbl) [117-119]. Another
therapeutic advantage of Cbi includes its relative solubility (about 5 times than Cbl),
and stability at room temperature, as well as its ability to be administrated
intramuscularly [35, 93, 105, 109, 116]. Cbi is the generic term used for
diaquocobinamide [(H2O)2Cbi2+] or its conjugate base, hydroxoaquocobinamide

22
[(OH)(H2O)Cbi+] [117, 119]. Cbi binds strongly to transmembrane proteins, placing a
challenge on its distribution [121, 122]. However, the dinitrocobinamide form
[(NO2)2Cbi] [6, 35] and the sulfite form [(SO3)2Cbi] [93] had been reported to be
fairly distributable in biological system. Research by Broderick et al. [115] revealed
that Cbi was several-fold more effective than Cbl in (i) reversing cyanide inhibition of
oxidative phosphorylation in mammalian cells; (ii) rescuing mammalian cells and
Drosophila melanogaster from cyanide toxicity; and (iii) reducing cyanide inhibition
of Drosophila Malpighian tubule secretion. Brenner et al. [93, 116] also showed that
Cbi was better at reversing cyanide toxicity than Cbl in cyanide exposed animals.
Adriano et al. [105] reported that Cbi has a higher affinity for nitric oxide than Cbl, an
additional advantage for Cbi’s greater efficacy as a cyanide antidote. Nitric oxide has
the ability to regulate the activity of cytochrome c oxidase, the main cyanide target.

Figure 1. 5. Structure of cobinamide without any ligands attached, and lacking the
dimethylbenzimidazole ribonucleotide (as in Cbl in Figure 1.4).
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1.4.3.2. Sulfanegen/3-Mercaptopyruvate (3-MP)
Sulfangen, a prodrug of 3-MP (i.e., sulfanegen converts to 3-MP upon
administration), is a potent cyanide antidote. 3-MP is a sulfur donor that converts
cyanide to thiocyanate by utilizing the ubiquitous cyanide detoxifying enzyme, 3mercaptopyruvate sulfur transferase (3-MPST) [6, 84, 92, 95, 96, 123], as outlined in
Scheme 1.4 [92]. 3-MPST is relatively more widely distributed in tissues, including
the central nervous system, and can be found both in the mitochondria and the
cytosol. These features of 3-MPST make it more advantageous for efficient
detoxification of cyanide than rhodanase (which is limited in distribution and found
only in the mitochondria) [6, 92]. Similarly to rhodanese, the mechanism of reaction
of 3-MPST involves generation of an enzyme-persulfide intermediate (3-MPST-3MP)
that reacts with cyanide to produce thiocyanate, and regenerates the free enzyme, 3MPST [96]. The sulfur donor for the 3-MPST is from the cysteine catabolite 3-MP
and the site of the persulfide formation is postulated to take place at Cys248 [96].
However, 3-MP decomposes rapidly and facilely in the blood. Therefore, to ensure
continuous supply, an intramuscular administration of sulfanegen is required for
cyanide detoxification [84, 92]. Interestingly, current research work by Chan et al.
[105] shows that combination of cobinamide and sulfanegen, when administered
intramuscular, gives a great promise as a new approach to treating cyanide poisoning.
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CO2Na

CO2Na
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Sulfanegen sodium

H2O

2 SH
CO2Na

OH

3-MPST
Singlet sulfur
O

Pyruvate

CNCO2Na

-SCN
Thiocyanate

Scheme 1. 4. Structure of sulfanegen sodium and the enzymatic transfer of sulfur
from 3-MSPT to pyruvate with concomitant conversion of cyanide (CN) to the
innocuous thiocyanate (-SCN) [92].

1.4.3.3. Dimethyltrisulfide (DMTS)
Dimethyl trisulfide (DMTS), is a promising next-generation cyanide antidote
that functions by acting as a sulfur donor to detoxify cyanide by converting it into
thiocyanate with or without rhodanese [56, 124]. The proposed mechanism for the
detoxification of cyanide by DMTS via rhodanese is well enumerated, but the nonenzymatic routes are not as well-understood [56]. Compared to thiosulfates, a recent
study shows that DMTS is about 40 times more effective than thiosulfates in-vivo in
the presence rhodanese, and about 80 times more efficacious than thiosulfate via nonenzymatic routes. In addition, studies by Kiss et al. [124] revealed that DMTS has
better efficacy than the Cyanokit (hydroxocobalamin) and the Nithiodote (sodium
nitrite and sodium thiosulfate) therapies. The main therapeutic feature of DMTS is its
relatively high lipophilicity, making it possible to facilely cross the blood brain barrier
[56]. It can also be administered intramuscularly [112, 125] and provides
cardiovascular protection [124]. However, recent studies by Dong et al. [126] shows
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that DMTS does react slowly with Hgb to form MetHb. They suggested that the
reaction of DMTS and Hgb could explain the lower recoveries of DMTS from fresh
blood in which the Hb/metHb ratio was higher than in aged blood.
1.5. Analytical Methods For Detection of Cobinamide derivatives in Biological
Fluids
Several methods, including colorimetric techniques, HPLC, UV, ICP-MS, and
currently HPLC-MS-MS have been used to analyze Cbi and its derivatives [6, 118,
127-131]. Absorbance-based techniques have relatively low sensitivity. The ICP-MS
method produces quite good sensitivity but lacks the method efficiency and detection
limit for the sample size expected, and complex sample matrix [118]. Alsberg et al.
[132] developed a method for the analysis of hydroxyalkyl derivatives of cobalamin
(i.e., hydroxypropyl cobalamine, OH-PrCbl), using HPLC with ESI-MS-MS and
ultraviolet diode array detection (UV-DAD). One of the methods made use of two
different mobile phases (eluent A and B, respectively) and two column systems:
Eluent A was acetonitrile and water with trifluoroacetic acid (TFA) added to a
concentration 0.4 mM (ACN/water with TFA), and Eluent B was made up of
ACN/water with 1-methylpiperidine. Column I and II used were Kromasil C18 (4.6
mm x 250 mm, 5 mm), and Zorbax C18 (2.1 x 150 mm, 3.5 mm), respectively. The
limit of detection obtained was 0.2 pg/mL. The analytical method by Schwenter et al.
[133] involved an LC-MS-MS method for the detection of hydroxocobalamin
(HOCbl) and cyanocobalamin (CNCbl) in swine plasma, obtaining an LOD of 1.0 μM
each for HOCbl and CNCbl. An online SPE HLB column (2.1 mm × 20.0 mm,
25 μm) was used for extraction, while a C18 Phenomenex Luna analytical column
(2.0 mm × 150 mm, 5 μm) was used for the analytical separation. Mobile phase A
consisted of 2.5 mM ammonium acetate in 50:50 methanol:water, (pH 4.0), and
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solvent B was 10% acetonitrile in water. Similarly, Mendes et al. [134] performed
pharmacokinetic studies for HOCbl in human plasma using HPLC-ESI-MS-MS. The
samples were extracted from the plasma by liquid-liquid extraction using 100%
ethanol, at -20°C, and separated with Prevail C8 analytical column (2.1×100 mm, 3
µm). Acetonitrile: water (50:50 v/v) was used as mobile phase A, while mobile phase
B was composed of 10 mM ammonium acetate with 0.1% formic acid. The limit of
quantification was 5 ng/mL. McCracken and Brittain [118] also reported an LC-ESIMS-MS method for the analysis of total cobinamide in swine plasma, following Cbi
‘total’ conversion to dicyanoCbi with excess cyanide in swine plasma. The lower
limit of quantification was 25 ng/L. The separation of the analyte was performed
using a Phenomenex Kinetex C18 column (2.1 × 150 mm, 2.6 µm). The mobile phase
composition was 0.01% formic acid in water (A) and 0.01% formic acid in
acetonitrile (B). Stutelberg et al. [6] gave the first comprehensive method for the
simultaneous analysis of cyanide antidotes Cbi and 3-MP using LC- ESI-MS-MS. The
sample preparation protocol for the Cbi was similar to that reported by McCracken
and Brittain. Separation was performed by using a Phenomenex Synergy Max RP
column (2.0 × 50 mm, 4 μm ) with the elution aided by 5-mMaqueous ammonium
formate with 10% methanol (Mobile Phase A) and 5-mM ammonium formate in 90%
methanol (Mobile Phase B). This analytical method produced an LOD of 0.2 µM and
a linear range of 0.5 to 50 µM with excellent precision and accuracy.
1.6. History, Formation and Exposure to Nitrosoamines
Most nitrosoamines are relatively polar (i.e., very soluble in water with low
log Kow) and have very small Henry’s constants (Table 1.3) [16]. The low log Kow of
NAs makes it difficult to extract them with organic solvents, and the small Henry’s
constants is an indication that they cannot be removed from water by aeration [16].
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Table 1. 3. Some physical and chemical properties of some NAs [135].

Chemical
Structure

Name

BPa
(˚C)

MPb
(˚C)

Henry’s
LCb

Color

(atm
m3/mol)

(physical
state)

(10-6)

Nnitrosodibutyla
mine (NDBA)

O

116 at
14
mmHg

N
N

Nnitrosodipropy
lamine
(NDPA)

O

206

N

13.2
<25

-126.6

at 37 ˚C

5.38

Water
Solubi
lity
(g/L)

Yellow
oil

Yellow
liquid

1.2
at 24
˚C

13

N

106
Nnitrosodiethyla
mine (NDEA)

3.63
O

O

214 at
760
mmHg

N
N

Nnitrosomethyle
thylamine
(NMEA)

<25

0.0489
-

at 37 ˚C

Yellow
liquid

at 24
˚C

103
at 24
˚C
300

1.82
O

N

163

-

151153

-50

at 37 ˚C

Yellow
liquid

N

Nnitrosodimethy
lamine
(NDMA)
Boiling point

N
N

Nnitrosopyrrolid
ine (NPyr)

a

175177

Slightly
Yellow
liquid

1.44
O

N
N

b

Melting point

at 25 ˚C

Yellow
liquid

at 20
˚C

103
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As early as the 1950s, analytical methods were developed for NAs because they
were suspected to be generated after adding nitrites as a meat preservative. Nitrite is
added to most meat to prevent the growth of Clostridium botulinum, and this leads to
high concentrations of NAs in bacon, sausage, and ham, but low in unprocessed meat
and salted fish [136]. Nitrosamines are formed in food when organic amines or their
derivatives react with nitrosating compounds. Besides food, NAs or their precursors
can be found in air, water, pesticides, herbicides, cosmetics, tobacco, and packing
materials [136-139]. Several studies in the US revealed that NAs can be formed at
drinking water treatment plants (DWTPs) and in their distribution systems, as
disinfection by-products. There are several ways by which nitrosomaines are formed
in water. Chloroamination is the major cause of NAs formation in drinking waters,
and amine forms the major precursor during the chloramination. It is important to
state that chloroamination is the low-cost option approved by the USEPA (Stage 2
DBP rule 2) for controlling trihalomethane and other disinfection by-products
(DBPs) [15]. However, studies have shown that about 5% of chloramine is in
dynamic equilibrium with dichloramine, which then reacts with secondary amines to
form the corresponding NA, as outlined in Scheme 1.5 [15, 140]. Mechanistically,
there is a nucleophilic attack on the unprotonated secondary amine on dichloramine,
yielding an unsymmetrical diakylhydazine intermediate. This is then followed by
oxidation of the diakylhydazine intermediate in the presence of dissolved oxygen to
afford the corresponding NA [15, 140]. The reaction is a slow process and it takes
days to accumulate the NA as a DBP. Another major route for NA formation in water
is chlorination processes in the presence of dinitrogen tetraoxide (N2O4), an inorganic
nitrogenous intermediate, which can lead to the nitrosation of amines to form NDMA.
During ozonation of wastewater or reclaimed waters, NDMA may be formed due to
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the reactions between trace amine-based organic chemicals and ozone itself. For
nitrosoamines to form by ozonization and chlorination, a bromide catalyst may be
required. Nitrosoamines can be formed in water from dissolved organic compound
precursors, such as dimethyl amine, ranitidine (i.e., a pharmaceutical drug for antacid
and antihistamine), and quaternary amines (e.g., the polymer polyDADMAC, anion
exchange resins, and shampoo constituents) [12, 15, 16, 141]. Other minor routes of
nitrosoamine formation in water include the formation of nitrosating species from a
nitrogen gas on activated carbon surfaces under aerobic conditions, and sunlight
photolysis of nitrite or UV photolysis of secondary chloramines [15].

2NH2Cl + H+

NHCl2 + NH4+
(b)

(a)

HN

CH3

(c) CH3

Cl
N
H
Chloramines

Other products

N
(d)

CH3

+ HCl

CH3
O2

O

N

N
(f)

CH3

NDMA

CH3

Scheme 1. 5. Showing the generalized formation of nitrosoamines in water during
disinfection via chloroamination [140, 142]. (a) monochloramine, (b) dichloramine,
(c) secondary amine (here, dimethylamine), (d) chlorinated unsymmetrical
diakylhydrazine (chloro dimethylhydrazine), and (f) the corresponding NA from the
secondary amine (c) (here, dimethyl nitrosomaine, NDMA is formed).
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The potential routes of most NA exposures to humans are ingestion, inhalation
and dermal contact. Food and tobacco products are the major external source of
human exposure to NAS, while small amount of NAs can also be produced internally
in the digestive tract [143, 144].
1.7. Metabolism, Toxicity, and Heath Effects of Nitrosoamines
The metabolism of NAs is catalyzed by cytochrome P-450 or CYP-450, which
is initiated by the reaction of the monooygenase reaction [137, 139]. Cyclic
nitrosoamines undergo α-hydroxylation in the presence of cytochrome P-450 or CYP450 to yield alkylating agents such as diazohydroxide and carbonium ions. These
metabolites facilely bind with DNA or may be involved in the generation of
electrophiles that have the propensity to react or bind with DNA to produce DNA
adducts, as outlined in Figure 1.6 [139]. The biotransformation of cyclic
nitrosoamines can also start by β-hydroxylation, but the mechanism is not fully
understood. In a similar fashion, acyclic or volatile nitrosoamine metabolism proceeds
solely by an α-hydroxylation to give formaldehyde, which alkylates DNA to form
DNA adducts or the diazohydroxide binds directly with DNA (Figure 1.7) [139].
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Cylic nitrosoamines
alpha-hydroxylation
or beta-hydroxylation

alpha-hydroxycyclic nitrosoamines
ring open

formation of the alkylating agent, alkydiazonium hydroxide

may bind directly with
DNA and cause mutation

may react with surronding water molecules
to form various alkylating agents

Figure 1. 6. General adduct formation mechanism and metabolism of cyclic
nitrosoamines [139].
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Acyclic nitrosoamines, e.g dimethylnitrosoamine
H3C
N

N

O

dimethylnitrosoamine

H3C
alpha hydroxylation

H3C
N

N

O

H2C HO
HCHO (formaldehyde)
alkylating agent; may bind with
DNA to form DNA adducts
H3C
N

monomethylnitrosoamine

N

O

H

CH3-N=N-OH

methyldiazonium hydroxide
an alkylating agent that binds with DNA

may also form methylcarbonium ion
that binds with DNA

Figure 1. 7. Generalized metabolic route and DNA adduct formation involving
acyclic nitrosoamines, such as dimethylnitrosoamine [139].

The formation of DNA adducts, or alkyl DNAs, due to the metabolism of
nitrosoamine leads to defects in the nucleotide base pairing, and consequently results
in mutations that disrupts cell function, metabolism and synthesis, leading to
apoptosis and cell damage [139].
1.8. Heath Effects of Nitrosoamines
The USEPA classified most nitrosoamines, including NDMA, NDEA, NDPA,
as likely to be carcinogenic to humans by a mutagenic mode of action under the
USEPA Guidelines for Carcinogen Risk Assessment, based on evidence of
carcinogenicity in animal studies [135]. The propensity of the metabolites of

33
nitrosoamines to bind cellular DNA leads to mutagenesis and carcinogenesis. These
carcinogenic and mutagenic metabolites alkylates several sites of DNA such as N-1,
N-3, N-7 positions of adenine N-3, N-7 and O6 of guanine, N-3, O2 of cytosine and
N3, O4, O2 of thymine and the oxygens of the phosphate group. The esophagus, oral
cavity, and pharynx are some of the reported sites of mortality due to the
carcinogenic effect of high levels of nitrosoamines [145]. Recent studies show that
nitrosoamines can also induce colorectal cancer in humans [146].
1.9. Current Methods for Analysis of Nitrosoamines in Drinking Water
The ‘standard’ methods for the detection and quantitation of most
nitrosamines (i.e, NDMA, NDEA, NDBA, NDPA, NMEA, and NPYR) in drinking
water are based on the EPA method 521 and the Standard Methods (SM), 6450B and
6450C [135].
The EPA Method 521 [135, 147], (Version 1.0) is the analytical method that
describes ‘Determination of Nitrosamines in Drinking Water by Solid Phase
Extraction (SPE) and Capillary Column Gas Chromatography with Large Volume
Injection and Chemical Ionization Tandem Mass Spectrometry (CI-MS-MS)’. It is
the method approved for use under the second cycle of the Unregulated Contaminant
Monitoring Rule (UCMR 2) to monitor the six nitrosamines with reference to their
health reference levels (HRLs) [135]. Essentially, the method involves the preconcentration of 0.5 L of a water sample containing a known concentration of a
surrogate analyte through an SPE cartridge absorbent made of coconut charcoal.
Elution of the anaylte (and possible contaminants, if present) from the SPE column is
performed with methylene chloride. The sample is dried, reconstituted, and a suitable
internal standard is added. The resulting solution is analyzed via GC-CI-MS-MS. The
detection limits (DL), as well as the lowest concentration minimum reporting levels
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(LCMRL) associated with this method for most common NAs, are summarized in
Table 1.4 [135]. SM 6450B also makes use of an SPE absorbent cartridge made of
granular carbonaceous adsorbent resin that is capable of achieving a concentration
factor of 500 to 1000, and an MDL between 0.5 to 2.0 ng/L. Method 6450C is an
alternative method that employs a liquid-liquid microextraction procedure, achieving
a concentration factor of 200, with MDL, ranging from 2 to 4 ng/L [135].

Table 1. 4. Some Figures of Merit (Performance metrics) for NA analysis via EPA
Method 521 [135].
DL (ng/L)

LCMRL

MRL

Recovery

RSD

(ng/L)

(ng/L)

(ng/L)

Range (%)

Range (%)

NDBA

0.36

1.4

4

79.7-104

2.9-16

NDEA

0.26

2.1

5

84.6-95.6

6.5-14

NDMA

0.28

1.6

2

83.7-94.7

3.8-12

NDPA

0.32

1.2

7

77.1-97.0

3.7-10.2

NMEA

0.28

1.5

3

81.4-91.0

4.5-9.6

NPYR

0.35

1.4

2

85.2-102

4.0-12

Analyte

Similar methods developed by many researches for the determination of NA
are also based on enrichment of the NA via SPE, followed by methylene chloride
extraction (elution), concentrating the eluate to less than 1 mL, and analyzing via
chromatographic (GC or HPLC) methods with tandem mass spectrometric (MS-MS)
detection [16]. Charrois et al. [16, 148] made use of an SPE column with dual
absorbent made of LiChroult EN (bottom layer) and an Ambersorb 572 (upper layer).
Dichloromethane was used for the elution of the NAs from the column, and the eluate
were dried with nitrogen to about 200 µL, and analyzed with GC coupled with MS
detector operating in a PCI mode and ammonia as a reagent gas. A concentration
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factor of 2500 was obtained. Similarly, Chen et al. [16, 149] compared three methods
that basically involved the use of an SPE with Ambersorb 572, a commercially
available cartridge SPE (CSPE), and a liquid-liquid microextraction system (MLLE).
For the graphitized black carbon with Ambersorb 572 sorbent system, elution was
carried out with dichloromethane, followed by solvent evaporation and GC-CI-MSMS analysis, giving a concentration factor of 1000. With the MLLE, dichloromethane
was also used for the extraction to a 0.5 mL and analyzed with same method, giving a
concentration factor of 200. Planas et al. [150] also employed two different
approaches (a) Ambersorb 572 and (b) EPA 521 cartridges with gas chromatography
high-resolution mass spectrometry (GC-HR-MS) to analyze NAs in drinking water. In
both sample preparation protocols, dichloromethane was used to elute the analytes,
followed by solvent evaporation with air (for a) or stream of nitrogen gas (b) and
subsequent analysis with GC-HR-MS. The minimum detection limits obtained with
this method ranged between 0.08 and 1.7 ng/L. Recently, a group of scientists at
Agilent reported a detection limit of 0.038 to 0.332 ng/L when they used the EPA 521
sample preparation protocol discussed above, and analyze their samples with low
resolution GC-MS instrument (i.e., the Agilent 5977A series GCMSD) [151].
Some SPE-HPLC-MS-MS methods have been extensively used for analyzing
NAs, including methods of Zhao et al. [152], Ripolles et al. [12], Krauss and
Hollender [16, 153], Qian et al. [18], and Wang et al. [154]. The first LC-MS-MS
method for the detection of NAs in drinking water was developed by Zhao et al. [152,
155], using an SPE cartridge packed with 350 mg of LiChrolut EN (bottom layer),
500 mg of Ambersorb 572 (middle), and glass wool (top). Dichloromethane was used
to elute the analytes, and the organic eluent collected and concentrated down to 200
µL under a high purity nitrogen stream in a 40 °C water bath. NDPA-d14 (100 µL of
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200 µg/L) was added as an internal standard and the analysis was carried out using a
HPLC-ESI-MS-MS method, obtaining a detection limits of 0.1 to 10.6 ng/L. Ripolles
et al. [12] used the EPA 521 SPE sample pre-concentration technique (i.e., coconut
charcoal EPA 521 cartridges with a 500 mL water sample) and analyzed by LC-MSMS with atmospheric pressure chemical ionization (APCI) in positive mode. The
detection limit achieved with this method was between 1 and 8 ng/L. Krauss and
Hollender [153] proposed a method for quantifying nine N-nitrosamines in drinking
and wastewater samples by LC(ESI)MS/HRMS, using a linear ion trap (LTQ)–
Orbitrap hybrid mass spectrometer, and combining Oasis HLB with a carbonaceous
sorbent for SPE-LTQ (obtaining an LOD of 0.2–3.9 ng/ L).
Qian et al. [156] developed an SPE-HPLC-MS-MS method where they used a
cartridge made up of vinyl/divinylbenzene polymer that was used to pre-concentrate
100 mL of water (instead of 500 mL in other methods), yielding an LOD of 0.01−2.7
ng/L. The method developed by Wang et al.[157] involved the use of Resprep EPA
521 cartridges followed by HPLC-EI-MS-MS, a technique originally published by
Planas et al. [150] to produce LOD between 0.1 and 0.7 ng/L.
Solid phase micro-extraction (SPME) techniques have been used in
conjunction with either GC or HPLC to analyze NAs extensively. Grebel et al. [16,
158] developed an SPME method coupled with gas chromatography with three gas
chromatography (GC) detection systems, including nitrogen chemiluminesence
detection (NCD), nitrogen–phosphorus detection (NPD) and chemical ionization mass
spectrometry (CI–MS). The LODs associated with this method and others discussed
above, are outlined in Table 1.5 [16, 135, 148, 149, 153, 158]. Hung et al. [159]
utilized SPME GC-CI-MS-MS to screen NAs in water, with LODs ranging from 3.2
to 15.2 ng/L.
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Table 1. 5. Characteristics of some NA analytical methods.
Sample
Volume
(mL)

Sample
Preparation

Analysis
Technique

LOD
Range
(ng/L)

Estimated
analysis
time
(min)

Qian et al. [160]

100

SPE

HPLC-ESIMS-MS

0.01-0.7

120

You [151]

500

SPE

GC-CI-MS

0.038-0.33

360

Planas et al. [150]

1000

SPE

GC-EI-HRMS

0.08-1.7

200a

Krauss and Hollender
[153]

500

SPE

HPLC-ESIMS-MS

0.10-2.40

220

Zhao et al. [152]

500

SPE

HPLC-ESIMS-MS

0.1-10.6

150

500-1000

SPE

GC-CI-MS-MS

0.20-0.66

150

Charrios et al. [148]

500

SPE

GC-CI-MS

0.70-1.30

200

Hung et al. [159]

4.5

SPME

GC-CI-MS-MS

3.2-15.2

100a

Ripolles et al. [162]

500

SPE

Cheng et al. [163]

500
500
100

Grebel et al. [158]

Method

Munch and Basset
[161]

1.0-8.0

100

SPE
CSPE
MLLE

HPLC-CI-MSMS
GC-CI-MS-MS
GC-CI-MS-MS
GC-CI-MS-MS

0.78-1.78
0.33-1.36
1.80-3.90

156
126
94

40
40
40

SPME
SPME
SPME

GC-NPD
GC-CI-MS
GC-NCD

1-890
30-138
57-193

75
75
75

Wang et al. [164]

0.1

LLE

GC-EI-MS

32-100.6

90

Current method

10

ICECLES

GC-EI-MS

0.2

200a

a

Methods with utilizing automated sample preparation
LOD = limit of detection; SPE = solid-phase extraction; SPME = solid-phase
microextraction; CSPE = cartridge solid-phase extraction; MLLE = microliquid liquid
extraction; ICECLES = ice concentration linked with extractive stirrer; HPLC = highperformance liquid chromatography; MS = mass spectrometry; ESI = electrospray
ionization; GC = gas chromatography; CI = chemical ionization; HR = high resolution; NPD
= nitrogen phosphorous detector; NCD = nitrogen chemiluminesence detector; EI = electron
ionization.
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1.10. Ideal Analytical Method /Technique For Analysis of Nitrosoamines
Because of the challenges associated with current methods for analysis of
NAs, it is very important to devise a method that may allow analysis of NAs at the
desired sensitivity from small sample volumes and more widely available analytical
instrumentation, such as low resolution GC-MS. In addition, the ideal analytical
method should be simpler, “greener’, and must have ‘automated’ sample preparation
protocols that should have a stark contrast to some of the sample preparation
techniques listed in Table 1.5 (i.e., SPE, MLLE, and LLE). ICE Concentration Linked
with Extractive Stirrer (ICECLES), a sample preparation protocol developed by
Maslamani et al. [165] qualifies for most of the criteria listed above. Chapter 3 details
the use of ICECLES-GC-EI-MS for the analysis of NDPA.
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CHAPTER 2. DETERMINATION OF FREE CYANOCOBINAMIDE BY
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS
SPECTROMETRY

2.1. Abstract
In recent years, Cobinamide (Cbi) has shown promise as a therapeutic for
cyanide poisoning. There are several forms of Cbi based on the identity of the ligands
bound to the cobalt in Cbi and these different forms of Cbi have divergent behavior
(e.g, the aquo and hydroxo forms of Cbi readily bind to proteins, limiting their
distribution significantly, whereas [Cbi(CN)2] does not). While current analysis
techniques only measure total Cbi, methods to elucidate the behavior of ‘available’
Cbi versus cyanide-complexed Cbi would be valuable for biomedical and
pharmacokinetic studies. Therefore, a method was developed for the analysis of
cyanide-complexed Cbi in plasma via liquid chromatography tandem mass
spectrometry (LC-MS-MS). Plasma samples were prepared by denaturing proteins
with 10% ammonium hydroxide in acetonitrile. The resulting mixture was
centrifuged, and the supernatant was removed, dried, and reconstituted. Cyanidecomplexed Cbi was then analyzed via LC-MS-MS. The limit of detection was 0.2
µM, and the linear range was between 1-200 µM. The accuracy was 100±17% and the
precision, measured by relative standard deviation (%RSD), was ≤18.5%. Carryover,
a severe problem when analyzing Cbi via liquid chromatography was eliminated
using a polymeric-based stationary phase (PLRP-S) and a controlled washing
protocol. The method allowed evaluation of the cyanide-bound and ‘available’ Cbi
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from treated animals and, when paired with a method for total Cbi analysis, allows for
estimation of Cbi utilization when treating cyanide poisoning.

2.2. Introduction
Current treatments for cyanide exposure (CN- and HCN, inclusively
represented as CN) include three general classes of agents: methemoglobin generators
(sodium nitrite, amyl nitrite, and dimethyl aminophenol), sulfur donors (sodium
thiosulfate and glutathione), and direct binding agents (hydroxocobalamin and
dicobalt edetate) [92]. While each type of treatment has been effective at countering
the toxic effects of cyanide, each has major limitations, especially during mass
casualty situations. For example, all cyanide approved antidotes require intravenous
administration [91].
Methemoglobin generators oxidize hemoglobin in the red-blood cells to
produce methemoglobin [166], a complex with high affinity for cyanide [105].
However, production of methhemoglobin leads to methemoglobinemia, which
reduces oxygen transport in the erythrocytes and tissues [60, 91, 167, 168]. This is
especially dangerous when smoke inhalation has occurred, causing concurrent
carboxyhemoglobinemia and methemoglobinemia [92]. Nitrites, such as sodium
nitrite, are also known to cause severe hypotension, cardiovascular instability and
hypoxia [60]. Nitrites can also cause oxidative stress on fetal hemoglobin in pregnant
patients [39]. It has been proposed recently that nitric oxide generated from nitrites
displaces cyanide bound to the active site of cytochrome c oxidase [84, 95-97],
restoring the activity of cytochrome c oxidase. The displaced CN may then be
scavenged by circulating MetHgb, or converted to SCN- in the presence of sulfur
donors [84]. Sulfur-donor antidotes detoxify cyanide by converting cyanide to
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thiocyanate with the help of sulfurtransferase enzymes (e.g., rhodanese and 3mercaptopyruvate sulfurtransferase) [169]. However, sulfur donors are limited due to
variable subcellular distribution of sulfurtransferase enzymes [169]. For example,
rhodanese is concentrated in the mitochondrial matrix of the liver and kidney, but is
not prevalent in the central nervous system [92]. Thiosulfate, the only U.S. FDAapproved sulfur donor cyanide antidote, also has a disadvantage of slow uptake into
cells. Large concentrations of sodium thiosulfate produce side effects such as nausea,
vomiting, local skin and muscle pain at the site of infusion, headache, and
disorientation [60]. Recently, other sulfur donor compounds, including 3mercaptopyruvate (3MP) [92, 105, 115, 170] and dimethyl trisulfide [97, 112, 114,
171, 172] have been suggested as more efficient sulfur donors for cyanide therapy.
While these novel sulfur donors have many advantages, they are still under
development. Direct binding agents offer an alternate mechanism for detoxifying CN
by sequestering cyanide from cytochrome c oxidase to effectively reduce the toxicity
of cyanide. One such binding agent is hydroxocobalamin (Cbl), which more strongly
binds cyanide than cytochrome c oxidase [39]. Cbl is the only U.S. FDA-approved
binding agent [39, 173] and is relatively safe and effective [92], but binds only one
cyanide ion per molecule, and has a very high molecular weight. Therefore, it requires
large doses (i.e., approximately 4 to 5 g) and intravenous administration to be
effective, limiting its use in mass casualty situations [92, 115]. Cobinamide (Cbi), the
penultimate precursor in the hydroxocobalamin biosynthetic pathway [92, 174], has
been suggested as an effective cyanide binding agent. To date, studies have shown
that Cbi is superior to current FDA-approved treatments, mainly due to its flexible
administration (typically intramuscular) and therapeutic index advantages [30, 93].
The greater effectiveness of Cbi is due to its extremely high affinity for cyanide (KF,
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overall

= 1022 M-1) [30, 115, 174], its ability to directly bind two cyanide ions, and its

relatively high solubility [115, 174]. Depending on the pH and ligands present,
cobinamide can exist in several forms, such as diaquocobinamide [Cbi(H2O)2]2+,
hydroxoaquocobinamide [Cbi(OH)(H2O)]+, and dihydroxocobinamide [Cbi(OH)2],
[120]. Cobinamide itself exists predominantly as [Cbi(OH)(H2O)]+ at neutral pH, as
[Cbi(H2O)2]2+ under acidic conditions (Pka=5.9), and as [Cbi(OH)2] under basic
conditions [175]. In the presence of cyanide, either one or both of the aquo or hydroxo
ligand(s) are replaced to produce [Cbi(CN)(H2O)]+, [Cbi(CN)(OH)], or [Cbi(CN)2]
[120, 175] depending on pH, the CN concentration, and the reaction time. Of course,
a variety of other ligands may bind to the Cbi, depending on its environment.
The multiple species of Cbi exhibit disparate kinetic, thermodynamic, and
biological behavior. For example, the aquo and hydroxo forms of Cbi significantly
bind to transcobalamin protein (TC), haptocorrin (HC), and intrinsic factors (IF),
while the dicyano form of Cbi does not. This likely results in substantially different
distribution of these species [176-178]. Several methods have been developed for the
determination of total Cbi by conversion to [Cbi(CN2)]0 utilizing a large excess of
CN. These methods include electrochemical, spectrophotometric, and
chromatographic techniques [6, 79, 115, 120, 174]. Although these methods perform
well for the analysis of total Cbi, they lack the ability to measure ‘available’ and
cyanide-bound Cbi. For example, we developed a method for the simultaneous
analysis of total Cbi and 3-mercaptopyruvate in swine plasma [6], while a different
group reported a method for the analysis of total Cbi alone, also in swine plasma
[179]. While these methods give valuable information as to the distribution and
kinetics of the Cbi species in aggregate, they fail to elucidate the interplay between
Cbi species and the contribution of these species to the effectiveness of Cbi. This
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information is necessary for gaining a complete understanding of the distribution and
pharmacokinetic profile of Cbi. Therefore, the development of a selective method for
the analysis of individual Cbi species is desired. Most importantly, the selective
analysis of cyanoCbi species (i.e., cyanoCbi is defined as Cbi bound to at least one
CN- ion) would allow determination of the pharmacokinetic behavior of cyanidebound Cbi. In combination with the determination of the total Cbi, factors
contributing to the efficacy of Cbi may be revealed. Such information may help in the
identification of more effective formulations of Cbi for treatment of cyanide.
The objective of this project was to develop a single analytical method for the
determination of plasma concentrations of cyanoCbi species, (i.e., [Cbi(CN)2] and
[Cbi(CN)Y]z, with Y representing a ligand bound to the Cbi and z representing the
formal charge of the complex). A secondary objective was to significantly reduce or
eliminate the well-known problem of severe carryover of Cbi during liquid
chromatography analysis [118].
1.10.

2.3. Experimental

2.3.1. Reagents and standards
All reagents were HPLC grade, unless otherwise noted. Sodium cyanide
(NaCN), potassium cyanide (KCN), urea, ammonium sulfate, acetonitrile, zinc
chloride, zinc acetate, sodium hydroxide, perchloric acid, and ammonium hydroxide
were all obtained from Fisher Scientific (Hanover Park, IL, USA). Millex®
tetraflouropolyethylene syringe filters (0.22 µm, 4 mm, Billerica, MA, USA) were
also purchased from Fisher Scientific. Sodium dodecylsulfate, potassium hydroxide,
potassium chloride, p-toluenesulfonic acid monohydrate, and urea, were supplied by
Sigma-Aldrich (St. Louis, MO, USA). Formic acid was obtained from Thermo
Scientific (Rockford, IL, USA). Water was purified to 18 mΩ-cm using a Water PRO
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PS system (Labconco, Kansas City, KS, USA). Aquohydroxo-cobinamide was
obtained from Dr. Gerry Boss, MD, Department of Medicine, University of
California-San Diego, La Jolla, USA [6, 116]. A stock solution of 20 mM
aquohydroxo-cobinamide was prepared by diluting the aquohydroxoCbi with deionized water and storing at 4°C in amber vials.
Calibration and quality control (QC) standards of dicyanoCbi were prepared
by adding 1 mole of aquohydroxo-cobinamide to 2 molar equivalents of NaCN
(dissolved in 10 mM sodium hydroxide), allowed to stand for 5 minutes, serially
diluting to the desired concentration, and spiking into plasma in a 9:1 volume ratio.
Spiked standards were mixed thoroughly and allowed to stand for 10 minutes prior to
sample preparation to ensure homogeneity.
Caution. Cyanide is toxic and hazardous to humans at blood concentrations of
∼20 μM or higher. HCN is produced from aqueous cyanide containing solutions near
or below a pH of 9.2. Therefore, all aqueous cyanide standards were prepared in 10
mM NaOH and handled in a well-ventilated hood with cyanide waste appropriately
labeled. Cyanide-containing waste was appropriately disposed via approved processes
at the institution where it was generated.
2.3.2. Biological fluids
Swine plasma (heparin anti-coagulated) and rabbit plasma (EDTA anticoagulant) used for method development and validation were purchased from Pelfreeze Biological (Rogers, AR, USA), and kept frozen at -80°C until used. Plasma
from rabbits exposed to cyanide and treated with 1H-tetrazole-5-acetylcobinamide
was obtained from the University of California-Irvine (Beckman Laser Institute). New
Zealand male rabbits (315 to 320 g, N = 3) were anesthetized with an initial
intramuscular injection of Ketamine HCl 50 mg/kg (Ketaject, Phoenix Pharmaceutical
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Inc., St. Joseph, MI) and Xylazine 5 mg/kg (Anased, Lloyed Laboratories,
Shenandoah, IA). After administration of anesthesia, a catheter was placed in the
animal’s marginal ear vein to administer continuous intravenous anesthesia with
Ketamine/Xylazine at 0.17 mL/min during central line placement. The rate of
anesthesia delivery was subsequently increased to 0.19 mL/min for the duration of the
experiment. Rabbits were ventilated at 100% O2 at 18 respirations per minute. Blood
samples were drawn prior to CN exposure to establish a baseline. NaCN (20 mg in 60
mL 0.9% NaCl) was administered intravenously at 1 mL/min. Blood samples were
drawn at 15 and 25 mins post-NaCN infusion start. After 30 mins of CN infusion, the
ventilator rate was reduced to 16 respirations per minute, and room air was used for
ventilation. Blood samples were subsequently drawn at 35 min of NaCN infusion and
until blood pressure reached a target value of 40-58 mm Hg systolic. At this trigger
point (designated as “time 0”), the antidote, 1H-tetrazole-5-acetylcobinamide (1
mL of 150 mM Cbi), was injected intramuscularly into the left front leg muscle.
Starting at 5 minutes post-antidote administration, blood was drawn into K2-EDTA
vacutainers (BD, Franklin Lakes, NJ) at 2.5, 5, 7.5, 10, 15, 30, 45, 60, and 90 minutes
(i.e., the post-antidote samples). The plasma was then immediately separated from
blood by centrifugation at 4 °C for 20 min. The plasma was transferred to a clean
microcentrifuge tube, flash-frozen in liquid nitrogen, and shipped overnight on dry ice
to South Dakota State University for analysis. Upon receipt, the plasma was stored at
-80 °C until analysis was performed. All rabbits were cared for in compliance with the
“Principles of Laboratory Animal Care’’ formulated by National Society for Medical
Research and the “Guide for the Care and Use of Laboratory Animals” prepared by
the National Institutes of Health [6, 180]. The animal study was approved by the
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University of California-Irvine Institutional Animal Care and Use Committee
(IACUC).
2.3.3. Sample preparation of Cbi species
Plasma samples were denatured by adding 700 µL of 10% ammonium
hydroxide in acetonitrile to 100 µL plasma. The samples were then vortexed briefly
(~10 seconds), and centrifuged at 16,500 x g for 20 minutes at 8 °C. The supernatant
(650 µL) was collected into a 2-mL centrifuge vial and further centrifuged for an
additional 10 minutes under the same conditions. Afterwards, the supernatant (600
µL) was transferred into a 4-mL glass vial and dried with N2. The samples were then
reconstituted in 10% acetonitrile, filtered with a 0.22 µm tetraflouropolyethylene
syringe filter, and analyzed. Other denaturing agents were tested, including potassium
chloride (1 g/mL), zinc chloride (1 g/mL), zinc acetate (1 g/mL), ammonium sulfate
(1 g/mL), p-toluenesulfonic acid monohydrate (1 mM), and sodium dodecylsulfate
[181]. Combinations of denaturing agents were also evaluated, including zinc chloride
and urea (1 g/mL each), zinc actetate and urea (1 g/mL each), and perchloric acid (4
mM):potassium hydroxide (1 M) [181]. However, these agents produced inadequate
recovery of cyanoCbi.
For total Cbi analysis, we used our previously published method [6]. Briefly, a
100 µL cyanide solution (10-mM KCN in 0.1 M NaOH) was added to 50-µL plasma
and heated on a heat block at 80 °C for 15 min. Then, acetone (600 µL) was added to
precipitate the proteins, followed by centrifugation, transfer of the supernatant, drying
under N2, reconstitution in 5 mM aqueous ammonium formate with 10% methanol,
and filtering prior to LC-MS-MS analysis.
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2.3.4. Initial MS-MS-Analysis
All mass spectrometric analysis was performed by an AB Sciex QTRAP 5500
MS (AB Sciex, Framingham, MA, USA) with electrospray ionization in positive
mode. Mass spectra were initially acquired by direct infusion of aqueous Cbi
solutions (10 µL/min) with scans of MS1 from 200-1200 Da over 1.6 minutes. The
entrance orifice potential was 180 V, and the collision cell exit potential was 11 V.
The curtain gas and ion source gases were operated at 30 and 40 psi, respectively. The
ion spray voltage was 5500 V with a temperature of 500 K, and the collision
activation dissociation (CAD) was set to “high”. The low energy collision-induced
dissociation tandem mass spectrometric analysis (CID-MS-MS) was conducted with a
linear accelerator (LINAC) collision cell of the triple quadrupole/linear ion trap
instrument. The CID-MS-MS was performed in multiple-reaction monitoring (MRM)
mode with optimum MRM parameters shown in Table 2.1. Analysis and data
acquisition was accomplished using Analyst software (Applied Biosystems, Version
1.6.3). The transitions (m/z) monitored for cyanoCbi were 1015.5 → 930.8 and
1015.5 → 988.5. We have seen in the past, and also in the current study, that the
1064.9 m/z transitions (i.e., dicyanoCbi with sodium) produce poor sensitivity, with
lower limits of detection, as compared to the 1015 transitions [6]. Consequently, the
1015.5 transitions were used for quantification and, when present above baseline
noise, the 1064.9 transitions monitored for identification of dicyanoCbi.
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Table 2. 1. Optimized MS-MS MRM parameters for cyanoCbi species.
Compounda

MS1 (m/z Da)b

MS3 (m/z Da)c

DP (V)d

CE (V)e

CXPf (V)

[Cbi(CN)2Na]

1064.9

930.8 (ID)g

263.11

97.47

11

[Cbi (CN)Y]z

1015.5

930.8 (Quant)h

249.42

75.91

11

[Cbi (CN)Y]z

1015.5

988.5 (ID)g

237.79

50.71

11

a

Y represents a ligand bound to the Cbi and z represents the formal charge of the complex
c
d
Precursor ion
Product ion
Declustering potential
e
f
Collison energy
Collision cell exit potential g Identification ion
h
(dicyanoCbi)
Quantification ion (cyanoCbi)
b

2.3.5. HPLC-MS-MS Analysis
Liquid chromatography-tandem mass spectrometry (LC-MS-MS) was
conducted on a Shimadzu High Performance-LC system (HPLC, LC-20AD,
Shimadzu Corp., Kyoto, Japan) coupled with the QTRAP described above. Samples
were separated by a polymeric reversed phased column, PLRP-S (300A, 50 x 2.10
mm x 3 micron) from Agilent Technologies (Santa Clara, California, USA). An
isocratic method of 100% acetonitrile over 5 minutes was used. The optimized
transitions (Table 2.1) were monitored.
Carryover is a major and well-known problem when analyzing Cbi species
[118]. Cbi can bind both column and LC-MS-MS components (e.g. the autosampler
syringe). In order to reduce day-to-day carryover of Cbi, a PLRP-S stationary phase
was used to avoid the strong interaction of Cbi with free silanols present in typical
reversed-phase stationary phases. Moreover, a cleaning protocol was devised to
eliminate residual Cbi in the LC-MS-MS components. The cleaning procedure was
based on addition of anions with high affinity for Cbi to the LC components and the
column to release bound Cbi as cyanide- or sulfite-complexed Cbi. The cleaning
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procedure consisted of 3 steps: 1) rinsing the LC instrumentation (minus column) via
injections of aqueous cyanide, 2) rinsing the column with sulfite-containing mobile
phase, and 3) injecting aqueous NaCN (in basic solution) into the complete LC-MSMS system and monitoring the detection of cyanoCbi. The flow chart in Figure 2.1
schematically represents the cleaning protocol for both the HPLC-MS-MS system and
the column. Following analysis of multiple Cbi samples (e.g., analysis of calibration
standards and samples from a model of treatment for cyanide exposure), the column
was removed from the LC-MS-MS. The LC autosampler and connections without
column were rinsed (0.25 mL/min) with water, 5% and 10% acetonitrile (ACN) for
15, 10, and 20 min, respectively, to unbound or weekly-bound residual sample
components into waste using the diverter valve on the MS. The mobile phase was
then changed to 100% ACN. Subsequently, injections (50 times) of aqueous cyanide
(100 µM CN in 10 mM NaOH) were performed to bind residual Cbi and allow its
release, as cyanoCbi, into the waste. On the last injection, the cyanoCbi signal was
evaluated to determine if residual Cbi was still present in the LC system (minus
column). If cyanoCbi was present, the injections of cyanide were repeated as
described above and the final injection was evaluated. This process was repeated until
no cyanoCbi was present in the eluant. Subsequently, 5 and 10% aqueous ACN
solutions (at 0.5 mL/min) were used to flush the system of NaCN and NaOH. The
column was separately washed on a different HPLC using an aqueous solution of
sodium sulfite and ACN (1:10 of 1 mM Na2SO3:ACN) at 0.1 mL/min (i.e., sulfite
strongly binds to Cbi, although not strongly as CN). After this, a 5%-ACN solution (4
hr) followed by 10% ACN (2 hr) were used to wash residual salt from the column at
0.05 mL/min. The column was then equilibrated to 100% ACN, and further cleaned
by performing at least 70 autosampler injections of 100 µM cyanide in 10 mM NaOH
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(40 µL each). The column was then equilibrated with 100% ACN and stored for
future use. Prior to sample analysis, the PLRP-S column was installed on the LC-MSMS system and 100 µM cyanide in 10 mM NaOH was analyzed by the cyanoCbi
method presented here to verify that residual Cbi was eliminated from the LC-MS-MS
system (i.e., cyanide strongly binds to Cbi to release any residual Cbi in the
autosampler or column which would appear as cyanoCbi during the LC-MS-MS
analysis). The absence of a cyanoCbi peak confirmed the instrument and the column
were free from residual Cbi (i.e., residual Cbi appears as a cyanoCbi peak in the
chromatogram). In our work, if a cyanoCbi was detected, following the procedure in
Figure 2.1, the signal was very small and repeated injections of 100 µM CN (≤10)
eliminated the residual Cbi. Although we did not observe a large residual cyanoCbi
peak following the procedure in Figure 2.1, if a large cyanoCbi is signal is present, the
overall cleaning procedure may need to be repeated multiple times to eliminate
residual Cbi from the LC-MS-MS components.
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Figure 2. 1. Flow chart for cleaning protocol for the LC-MS-MS. ACN =
acetonitrile.
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2.3.6. Method Validation
FDA guidelines [182-186] were followed for bioanalytical method validation.
For the determination of the limit of detection (LOD), multiple concentrations of
dicyanoCbi (i.e., 100, 200, and 500 nM) were spiked in plasma, and analyzed by the
method. The LOD was defined as the concentration that reproducibly produced a
signal to noise ratio of 3, with the noise calculated as the peak-to-peak noise of the
blank (i.e., non-spiked plasma) over the retention time of cyanoCbi. The linear range
was determined by analyzing dicyanoCbi calibration standards in plasma (each in
triplicate) at nine different concentrations ranging from 0.5 to 200 µM (i.e., 0.5, 1, 2,
5, 10, 20, 50, 100, and 200 µM). The criteria used for the lower limit of quantification
(LLOQ) and upper limit of quantification (ULOQ) were as follows: (1) calibrator
precision (measured as percent relative standard deviation, %RSD) of ≤20% and (2)
an accuracy of 100±20% of the nominal calibrator concentration back-calculated from
the calibration curve. The cyanoCbi concentration was back-calculated from the
calibration equation using the signal of each calibrator and then averaged. Inter- and
intra-assay precision and accuracy were determined by analyzing low (3.5 µM),
medium (35 µM) and high (150 µM) quality control (QC) standards in quintuplicate.
These QCs were not included in the calibration curve. DicyanoCbi calibration curves
were prepared each day of analysis.
For stability studies, QCs (low and high) were stored at various temperatures
and analyzed at multiple storage times. The short-term stability includes autosampler
stability (i.e., prepared QCs stored in the autosampler at 15 °C) and bench top stability
(i.e., prepared QCs stored on the bench top at room temperature (RT)). For both
autosampler and bench top stability, QCs were analyzed immediately and after 2, 4, 8,
12, and 24 hours. Stability for each experiment was measured as a percentage of the
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original QC signal (i.e., the QC analyzed immediately), with samples considered
stable if the stored sample produced 100±20% of the original signal.
The recovery was evaluated by comparing QCs (low, medium and high)
prepared in plasma to equivalent concentrations of QCs prepared in aqueous solution.
The plasma samples were prepared using the sample preparation procedure described
above, but the aqueous samples did not go through the sample preparation, except that
they were dried, and reconstituted in 10% aqueous ACN. The standards were prepared
in quintuplicate, and the recovery was calculated as a percentage of the average signal
in plasma compared to the aqueous standards. Matrix effects were evaluated by
comparison of the slope of an aqueous calibration curve to that of plasma. A matrix
effect was said to be present if the slope of the calibration curve in water samples was
significantly different from that in plasma samples.
1.11.

2.4. Results and Discussion

2.4.1. Sample Preparation and Analysis of cyanoCbi
In previous work, Cbi has been measured as total Cbi by adding excess
cyanide to convert all Cbi species to dicyanoCbi [6, 118, 120, 127]. In this study, 10%
ammonium hydroxide in ACN, as a denaturating solution, coupled with two-step
centrifugation allowed extraction of cyanoCbi species, as opposed to total Cbi. It is
important to note that other chaotropic and kosmotropic agents were tested (results
not shown), but the ammonium hydroxide/acetonitrile combination was the only one
which produced acceptable recoveries of cyanoCbi. The ammonium hydroxide was
used to disrupt ionic interactions, likely disrupting salt bridges formed between the
cobalt in the cobinamide and negatively charged moieties in the plasma protein
structure. The ACN lowers the dielectric constant of the resulting solution to
precipitate plasma proteins and simultaneously disrupts hydrophobic and hydrogen
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bond interactions in the protein. The combination of these two denaturing agents
produced acceptable recoveries of cyanoCbi for analysis. We observed that any
further increase in the percentage of ammonium hydroxide concentration and/or
increase in the contact time during the deproteinization process produced a decrease
in the recovery of cyanoCbi. This was likely caused by a shift in the equilibrium or
kinetic stability of the Cbi species, resulting from increased hydroxo forms of Cbi
with increased pH. After denaturing the proteins, the sample was centrifuged, and the
supernatant was dried and reconstituted for analysis. The sample preparation for the
method presented here is relatively simple and easy, and the chromatographic method
is shorter as compared to other methods [6, 118]. Moreover, the stationary phase
chosen for this method is much less likely to bind Cbi under the chromatographic
conditions used. Figure 2.2 shows the chromatogram of cyanoCbi (eluted at 0.85
minutes) analyzed from spiked swine plasma. The chromatographic peak shape
(As=1.3) and resolution were excellent (i.e., there were no other significant present in
the chromatogram). The chromatographic run was 5 minutes in total. In future work,
we will evaluate the necessity of the relatively long equilibration time following
elution of cyanoCbi (i.e., the method is isocratic, allowing for no equilibration time
between runs, and cyanoCbi elutes within the first minute).

Abundance (arbitrary unit)
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DicyanoCbi-spiked plasma (1015 to 930)
DicyanoCbi-spiked plasma (1015 to 988)
Non-spiked DicyanoCbi (1015 to 930)
Non-spiked DicyanoCbi (1015 to 988)
0

1

2

3

4

Time(minutes)
Figure 2. 2. LC-MS-MS chromatograms of dicyanoCbi-spiked and non-spiked swine
plasma. CyanoCbi elutes at 0.85 min. The extra 4 minutes (after the elution of the
analyte) allowed for enough equilibration and possible elimination of some of the
residual Cbi in the system.
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Figure 2. 3. Peaks obtained after injection of 100 µM NaCN )in 10 mM NaOH)
following one validation analysis (i.e., approximately 42 dicyanoCbi-spiked swine
plasma samples were analyzed), but before performing the cleaning protocol (Figure
1). Chromatograms with the column (cyanoCbi eluted at 0.85 min) and after removing
the column (cyanoCbi eluted at 0.25 min) are shown. The presence of cyanoCbi
without the column shows that Cbi is bound to extra-column components of the LCMS-MS system. The increased signal of cyanoCbi with the column attached indicates
that some residual Cbi is also associated with the column. The inset presents the
analysis of cyanoCbi (via injection of 100 µM CN) following the cleaning protocol,
showing undetectable Cbi, which demonstrations the excellent performance of the
protocol to eliminate carryover.
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Cbi has an extremely high affinity for oxide surfaces. Therefore, common
reversed-phase chromatography stationary phases, which have a silica-based solid
support (e.g., C18), are poor choices for Cbi analysis, even though multiple methods have
been published using this approach [6, 118], including one from our group. In fact, the
challenges associated with residual Cbi were vividly reported by McCracken and Brittain,
who used a reversed-phase C18 column (i.e., Phenomenex Kinetex C18 column) [118].
The PLRP-S stationary phase and the acetonitrile mobile phase used in this study
minimized carryover that has plagued Cbi analysis. Although carryover was greatly
decreased when using the PLRP-S column, carryover was still evident in the method
presented in this study (Figure 2.3). This is likely caused by sorption of Cbi to a number
of high affinity sites in the autosampler, LC connections and the column. Therefore, we
devised a wash protocol to remove residual Cbi from the column and LC components
(Figure 2.1). To evaluate the extent of residual Cbi, an aqueous cyanide solution (100 µM
in 10 mM NaOH) was injected via the autosampler (40 µL) and analyzed via the method
presented here. Cyanide has a high affinity for Cbi, releasing bound Cbi from the LCMS-MS system as cyanoCbi, allowing its detection via the tandem mass spectrometry.
Therefore, if bound Cbi is present in the LC-MS-MS, a cyanoCbi peak will be present in
the chromatogram following injection of cyanide. Figure 2.3 shows the residual Cbi
detected in the complete LC-MS-MS system, when the column is attached (elution at
0.85 minutes), and the LC-MS-MS system with the column removed (elution at 0.25
minutes) immediately after a full-day validation experiment (i.e., approximately 42 Cbi
containing samples ranging from 0.5 to 200 µM). It is evident that Cbi does bind to both
column and the other components of the LC-MS-MS system with approximately one-
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third of the cyanoCbi signal remaining after removal of the PLRP-S column. However,
with the polymeric stationary phase coupled with the cleaning procedure devised,
residual Cbi was eliminated, as clearly shown in the Figure 2.3 inset, where a
chromatogram of cyanoCbi (i.e., injection of 100 µM NaCN in 10 mM NaOH) after
using the cleaning protocol shows cyanoCbi was not detected.
2.4.2. Limit of detection, sensitivity and linear range
The LOD of cyanoCbi from plasma was 200 nM, which is the same as that
obtained in our previous total Cbi method (200 nM) [6]. It is likely that the LOD was the
same for the current method, even though only cyanoCbi was measured, because binding
of Cbi to the column was minimized.
The LLOQ and ULOQ were 1 and 200 µM, respectively. This represents over two
orders of magnitude for the linear range (LR). It should be noted that 200 µM was the
highest concentration tested, therefore, the ULOQ for the method may be higher than 200
µM. The LR is much improved from our previous work [6] and that which was reported
by Boss et al. [187]. This, again, is likely because the interaction of Cbi with the
chromatographic stationary phase was minimized. The LR of this method is well-suited
for translational studies, including pharmacokinetic analysis of cyanoCbi [6]. The
regression equations, correlation coefficients (R2), and the Percent Residual Accuracies
(PRAs) [188] for the 3-day validation study are outlined in Table 2.2. The PRA values
for all the calibration curves generated for the 3-day validation process was ≥90% (Table
2.2), indicating a good fit over the entire linear range [188]. In addition, the precision and
the accuracy of the calibration curves were acceptable (Table 2.3) [182-184, 186]. The
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day-to-day inconsistency in the slope and intercept over the 3-day validation study
require that a calibration curve be prepared for each day of analysis.

Table 2. 2. Regression models, R2 and PRA values for calibration curves over a 3-day
period.

Day

Calibration Equationa

R2

PRAb

1

y = 81397x-29620

0.9842

90.2

2

y = 42027x-18780

0.9872

90.2

3

y = 163762x-95040

0.9914

92.2

a

Equation in the form of y = mx + b, where x = cyanoCbi concentration
(µM) and y = the peak area abundance of the 1015→930 m/z transition
from the LC-MS-MS chromatogram.
b
Percent Residual Accuracy [188].

2.4.3. Accuracy and precision
The intra- and interassay accuracy and precision were determined by analyzing
low, medium and high QCs in quintuplicate over three different days, with the results
summarized in Table 2.3. The intraassay precision for the cyanoCbi species in swine
plasma was <18.5% RSD, while the accuracy was 100±18%. The interassay accuracy and
precision were 100±17% and <16% RSD, respectively. Even though the precision and
accuracy are slightly worse as compared to the total cobinamide methods presented by
Ma et al. [117], Stutelberg et al. [6], and McCracken and Brittain [118], the overall
precision and accuracy for this method were acceptable [182-184]. The accuracy and
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precision are likely worse for the current method because of the increased variability in
the recovery of cyanoCbi using the 10% ammonium hydroxide versus a large excess of
cyanide to measure the total Cbi [6, 118, 127].

Table 2. 3. Intra- and interassay accuracy and precision for the analysis of dicyanoCbispiked swine plasma.
Nominal
Intraassay

Intraassay

Interassay

Interassay

Accuracya (%)

Precisiona (%)

Accuracyb (%)

Precisionb (%)

3.5

100±14

<18.5

100±14

<16

35

100±17

<12.5

100±17

<11

150

100±16

<6.5

100±8

<9

Conc. (µM)

a

QC method validation for Day1 (N=5)

b

Average of QCs for the 3 different days of

validation (N=15)

2.4.4. Stability, recovery and matrix effects
In order to reduce the high variance associated with residual Cbi from run-to-run
for the stability studies, the short-term stability studies were carried out for the low QC
first, followed by the high QC on separate days. The benchtop and autosampler (15°C)
stability fell within 100±14% over 24 hours. The analyte was stable for at least 30 days in
a standard refrigerator at 4 °C. As shown in Table 2.4, these results are consistent with
what was reported earlier [6, 118].
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Table 2. 4. Stability profile for total Cbi for current and previous studies.
Stability expt.

Ref.

Total Cbi stability

Long-term

[6]

CSa

≥30 days for 1.5 and 35 µM at 4, -30, and -80 °C
≥60 days for 0.072 and 7.2 µM (reported as 75 and 7500
ng/mL) at -70 °C
≥30 days for 3.5 and 150 µM at 4 ºC

[6]

≥24 hours for 1.5 and 35 µM at RT

CSa

≥24 hours for 3.5 and 150 µM at RT

[6]

3 cycles; freezer at -80 °C

[118]

3 cycles; freezer at -70 °C

[118]

Bench-top

Freeze-thaw

Autosampler

[6]
[118]
CSa

a

≥24 hours for 1.5 and 3.5 µM at 15 °C
≥4 days for 0.072 and 7.2 µM (reported as 75 and 7500
ng/mL) at 2-8 °C
≥24 hours for 3.5 and 150 µM at 15 °C

Current study

The matrix effect was evaluated by comparing the slopes from the calibration
curves of the analyte in an aqueous matrix to that of plasma. The slope of the calibration
curve in the plasma matrix was 0.4 times that of the aqueous matrix calibration curve,
which indicates a considerable matrix effect. The matrix effect produced in this study is
similar to what we reported previously for total Cbi analysis [6]. The recoveries of
cyanoCbi for the low, medium and high QCs were 20, 40, and 50%, respectively.
Stutelberg et al. [6] reported recoveries of total Cbi of 29% (for the low QC), 29%
(medium QC) and 33% (high QC), while McCracken and Brittain reported 56%, 59%,
and 62% for the low, medium, and high QCs, respectively [118]. The increased
variability of the recovered Cbi compared to other studies is likely due to increased
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variability when extracting cyanoCbi with 10% ammonium hydroxide as compared to
analysis of total cyanide using excess cyanide. Since the matrix effect is a component of
the signal recovery, the matrix effect is responsible for most of the signal loss seen,
except for the low QC.
2.4.5. Analysis of Free CyanoCbi in Exposed Animals
The validated method was applied to analyze free cyanoCbi from the plasma of
1H-tetrazole-5-acetylcobinamide (Cbi)-treated rabbits. Representative chromatograms of
rabbit plasma obtained prior to cyanide exposure and plasma from the same rabbit
following cyanide exposure and Cbi treatment (10-min post-treatment) are shown in
Figure 2.4. Analogous to Figure 2.2, the cyanoCbi peaks were sharp and symmetrical.
Moreover, the method was extremely selective, with no interfering peaks present in the
pre-exposed rabbit plasma over the entirety of the chromatogram.
The cyanoCbi concentration, following IM-Cbi treatment of cyanide-exposed
rabbits, is plotted in Figure 2.5. The cyanoCbi concentration is around 1 µM at 2.5 min
following IM Cbi administration and increases to about 35 µM by 60 min. This
progressive increase in cyanoCbi species is expected as the antidote distributes into the
circulatory system from the muscle, binding more cyanide to produce more cyanoCbi.
This data definitively shows that cyanoCbi is produced in-vivo from the treatment of
cyanide poisoning via administration of Cbi (i.e., without addition of excess cyanide for
analysis) and, to our knowledge, is the first study to do so. Therefore, the hypothesized
mechanism of treatment of Cbi for cyanide poisoning, direct binding of cyanide, was
verified for the first time by this study.
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In conjunction with the cyanoCbi method, the total Cbi [6] at 7.5, 10, and 15 min
post-treatment was evaluated (Figure 2.5, inset). The difference between cyanoCbi and
the total Cbi was considered ‘available’ Cbi. As evident by the inset, the total Cbi
concentration increased progressively from 7.5 to 15 min, while the cyanoCbi increased
from 7.5 to 10 min and then decreased slightly from 10 to 15 min post-treatment. The
available Cbi increased generally linearly from 7.5 to 15 min. In terms of the percentage
of Cbi available, the percentage of cyanoCbi, with respect to the total Cbi, was
approximately 65%, 65%, and 50% at 7.5, 10, and 15 min, respectively. Therefore, the
‘available’ Cbi was 35%, 35%, and 50%. The increasing ‘available’ Cbi from 7.5 to 15
min is due to increased availability of the Cbi in the circulatory system as it distributes
from the muscle following IM injection. The relatively stable percentage of cyanoCbi
versus the total Cbi is likely due to the binding of CN by Cbi being governed by
equilibrium constants. Although this study is a good first step in evaluation of the
availability of Cbi, a more comprehensive pharmacokinetic/pharmacodynamic study
should be performed over a longer time period than presented here (i.e., allowing the
elimination phase to be evaluated) with analysis of cyanoCbi and total Cbi over the entire
duration of the experiment.
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Plasma from CN-exposed Cbi-treated rabbit
Plasma from a rabbit before CN-exposure
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Figure 2. 4. CyanoCbi (1015→930) chromatograms from rabbit plasma pre-CNexposure and pre-treatment and 10-min post-treatment from the same animal. The peak
shape was sharp, similar to what was obtained from the method developed.
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Figure 2. 5. CyanoCbi concentrations (circles) for a cyanide-exposed rabbit treated with
1H-tetrazole-5-acetylcobinamide. Inset: Concentrations of total, cyano and ‘available’
Cbi concentrations at 7.5, 10 and 15 min following the administration of antidote. The
‘available’ Cbi was calculated as total Cbi minus the cyanoCbi.

1.12.

2.5. Conclusion
An LC-MS-MS method for the detection of available cyanoCbi was developed.

The method was applied for the detection of available cyanoCbi species in plasma and
definitively show that cyanide is bound to Cbi in-vivo. The careful selection of a
polymeric PLRP-S column and the cleaning protocol presented here are vital for the

100
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analysis of Cbi and other compounds that have similar binding characteristics. The
availability of this method should allow more comprehensive analysis of the behavior of
Cbi for treatment of cyanide poisoning. In future, the method should be applied to a
more comprehensive pharmacokinetic study.
1.13.
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CHAPTER 3. ULTRATRACE ANALYSIS OF NITROSODIPROPYLAMINE IN
DRINKING WATER BY ICE CONCENTRATION LINKED WITH
EXTRACTIVE STIRRER (ICECLES) AND LOW-RESOLUTION GAS
CHROMATOGRAPHY-MASS SPECTROMETRY

3.1 Abstract
Nitrosoamines (NAs) are potent mutagens, carcinogens, and teratogens and are
produced in drinking water as chlorination disinfection by-products. The US EPA
estimates a 10-6 cancer risk of 0.2–20 ng/L for most NAs in drinking water and
unregulated contaminant monitoring minimum reporting levels (MRL) range from 2-7
ng/L (ppt). Analysis of NAs at these ultratrace concentrations is extremely difficult,
requiring sophisticated instrumentation and laborious sample preparation procedures. An
advanced sample preparation technique, ICE Concentration Linked with Extractive
Stirrer (ICECLES), coupled to a low-resolution gas-chromatography mass-spectrometry
instrument was used to analyze NDPA (MRL = 7 ng/L (ppt)). ICECLES allowed ultratrace analysis of NDPA, producing an LOD of 0.2 ng/L, and a linear range of 2 to 50
ng/L (using an internal standard, NDPA-d14). Both inter- and intraassay precision were
≤13%RSD, while the method accuracy was 100±17.5%. The ICECLES method was
applied to screen for possible NA contamination in selected drinking water sources. The
concentration of NDPA in one drinking water source was 2.38±0.34 ng/L. While NDPA
was detected in the two other municipalities tested (i.e., concentrations > 0.2 ng/L), it was
not quantifiable.

68
3.2. Introduction
Nitrosoamines (NAs) are potent mutagens, carcinogens and teratogens [20, 189191]. They are highly toxic to human bladder tissue [192] and are associated with
drinking water, food, and soil [20]. NAs have the general structure R1N(–R2)–N=O,
where an N-nitroso (N–N=O) functional group is typically bonded to two alkyl groups
through the amine nitrogen [193]. Table 3.1 shows the structures of the most common
nitrosoamines, along with some of their physical properties. As seen in Table 3.1, the
NAs have a unique combination of being highly carcinogenic, and having relatively high
polarity, as quantified by relatively low octanol-water partition coefficients (i.e., log Kows
range from -0.44 to 3.13). As a result of their high polarity, most NAs are difficult to
extract with organic solvents and non-polar solid sorbents [17], making the analysis of
low NA concentrations very difficult.
Common sources of NAs or their precursors can be found in food, agrochemicals, tanned leather products, solvents, cutting fluids, drugs, plastics, rubber
additives, detergents, and ground water/drinking water [194]. Drinking water is perhaps
one of the most concerning routes for NA exposure [12]. NAs are formed during the
water purification process as a disinfection byproduct (DBP) during chlorination and
chloramination [13-16]. Disinfectants such as chlorine, ozone, chlorine dioxide, or
chloramines react with naturally occurring organic matter or anthropogenic contaminants
to produce NAs [13-19]. The presence of NAs in drinking water can also result from
contamination by industrial and or agricultural sources [13, 20], or from anion exchange
resins [21] (i.e., anion exchange resins used to remove anionic contaminants from
drinking can produce higher NA levels in finished products).
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Because of the carcinogenic nature of NAs, many established regulatory
agencies have limited the concentration of NAs in drinking water (Table 3.1). For
example, the U.S. Environmental Protection Agency (US EPA) estimated a lifetime 10−6
cancer risk from the consumption of drinking water containing 0.2-20 ng/L of NDMA,
NMEA, NDEA, NDPA, and NDBA [13, 195, 196]. In March 2010, the US EPA also
categorized NDEA, NDBA and NDPA as candidate drinking water contaminants and
designated them for unregulated contaminant monitoring at 2 to 7 ng/L [16, 20]. The
California EPA set the 10 -6 cancer risk levels of NAs between 1 and 15 ng/L [197].
Moreover, the California Department of Health Services (CDHS) set a notification level
of 10 ng/L for NDEA, NDPA, and NDMA [12, 191].
Because each of these concentration limits are considered ultratrace, and
because NAs are relatively polar (Table 3.1), it is very difficult to quantify them at
these levels. Therefore, quantification of NAs has required both highly sensitive
analysis techniques and arduous sample preparation. Several analytical methods have
been employed to detect NAs in water samples, including gas or liquid chromatography
with nitrogen-phosphorous detector (NPD) [150, 190, 191, 198], thermal energy
analyzer detector (TEA) [150, 190, 191], fluorescence detector (FD) [150, 191, 199],
and mass spectrometry (MS) detection [12, 150, 191, 198, 200, 201]. These techniques
combined with sample preparation techniques such as solid-phase microextraction
(SPME), liquid–liquid (LLE) and solid-phase extraction (SPE), have produced detection
limits approaching the low ng/L [191]. However, very large sample volumes (e.g. 5001000 mL), long analysis times (e.g. 200 minutes), and sophisticated/expensive
instrumentation such as GC-MS/MS, GC-HRMS, and HPLC-MS-MS are necessary to
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reach the desired limits of detection [12, 191]. Therefore, methods capable of ultratrace
analysis of NAs are typically too costly and time-consuming to routinely analyze NAs
from drinking water sources [191]. Moreover, most institutions are not equipped with the
sophisticated instrumentation necessary to perform these methods [191]. Table 3.2
compares methods of analysis of NDPA. One low resolution GC-MS method was
recently developed by You using SPE was able to analyze NDPA to an LOD of 0.332
ng/L [151], but it involved a long and arduous sample preparation method involving
passing 500 mL of water through an SPE column, elution with a hazardous solvent,
evaporation of the solvent to a 1 mL volume (methylene chloride).
A novel sample preparation technique developed in our laboratory, coined ICE
Concentration Linked with Extractive Stirrer (ICECLES), may allow analysis of NAs at
the desired sensitivity from small sample volumes and more widely available analytical
instrumentation [165]. ICECLES is the combination of freeze concentration and stir bar
sorptive extraction. This process involves progressive freezing of an aqueous solution
containing the analyte, while rapidly stirring and pre-concentrating analytes into a
sorptive stir bar. After the analytes are extracted into a stir bar, they are desorbed by
heating the stir bar or are back extracted into a solvent, and then analyzed. The main
advantages of ICECLES are higher extraction efficiencies, the ability to extract relatively
polar analytes from aqueous solutions, and greater recoveries for more volatile
compounds [165].
The objective of the current study was to couple ICECLES with more readily
available low resolution GC-MS instrumentation in order to detect NDPA from drinking
water at relevant ultratrace concentrations (5-7 ng/L) from low sample volume and
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relatively short preparation time. Because individual NAs are not typically found in
isolation, NDPA may be a potential probe indicator of NA contamination. Upon finding
NDPA above an acceptable limit, a more sophisticated technique to simultaneously
analyze multiple NAs may be performed.
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Table 3. 1. Structures, physical properties, toxicity, and reporting levels of selected
nitrosoamines.

Name

log
Kowa

10-6 Cancer
Risk (ng/L)

MRL
(ng/L)

198.22

3.13

-

-

158.24

2.63

6c, 3d

4e

130.19

1.36

5c,d

7e, 10f

116.12

-0.44

5c,d

-

114.15

0.36

3.5c

-

102.14

0.48

0.2c, 1d

3e, 10f

100.12

-0.19

20c, 15d

2e

N

88.11

0.04

2c, 1.5d

5e

N

74.08

-0.57

0.7c, 3d

2e ,10f

Ph

N-nitrosodiphenylamine
(NDPhA)b
N-nitrosodibutylamine
(NDBA)

Molar mass
(g/mol)

Chemical Structure

O

N
N

O

Ph

N
N

N-nitrosodipropylamine
(NDPA)

O

N
N

N-nitrosomorpholine
(NMorph)

O
O

N
N

N-nitrosopiperidine (NPip)

O

N
N

N-nitrosodiethylamine
(NDEA)

O

N
N

N-nitrosopyrrolidine
(NPyr),

O

N
N

Nnitrosomethylethylamine
(NMEA)

O

N-nitrosodimethylamine
(NDMA)

O

a

N

N

Base 10 log of octanol-water partition coefficient [16, 156, 195, 196] b Ph = phenyl group (C6H5).
c
US EPA 10-6 cancer risk level [197, 202] d California EPA 10-6 cancer risk level [197, 202, 203]
e
US EPA second Unregulated Contaminant Monitoring Rule (UCMR2) minimum reporting level
[16, 193]
f
California Department of Health Services notification level [197, 202, 203]
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Table 3. 2. Characteristics of some NA analytical methods (ng/L).
Sample
Volume
(mL)

Sample
Preparation

Analysis
Technique

LOD
Range
(ng/L)

Estimated
analysis
time (min)

Qian et al. [160]

100

SPE

HPLC-ESI-MSMS

0.01-0.7

120

You [151]

500

SPE

GC-CI-MS

0.0380.332

360

Planas et al. [150]

1000

SPE

GC-EI-HRMS

0.08-1.7

200a

Krauss and Hollender
[153]

500

SPE

0.10-2.40

220

Zhao et al. [152]

500

SPE

0.1-10.6

150

500-1000

SPE

GC-CI-MS-MS

0.20-0.66

150

Charrios et al. [148]

500

SPE

GC-CI-MS

0.70-1.30

200

Hung et al. [159]

4.5

SPME

GC-CI-MS-MS

3.2-15.2

100a

Ripolles et al. [162]

500

SPE

Cheng et al. [163]

500
500
100

Grebel et al. [158]

Method

Munch and Basset
[161]

HPLC-ESI-MSMS
HPLC-ESI-MSMS

1.0-8.0

100

SPE
CSPE
MLLE

HPLC-CI-MSMS
GC-CI-MS-MS
GC-CI-MS-MS
GC-CI-MS-MS

0.78-1.78
0.33-1.36
1.80-3.90

156
126
94

40
40
40

SPME
SPME
SPME

GC-NPD
GC-CI-MS
GC-NCD

1-890
30-138
57-193

75
75
75

Wang et al. [164]

0.1

LLE

GC-EI-MS

32-100.6

90

Current method

10

ICECLES

GC-EI-MS

0.2

200a

a

Methods with utilizing automated sample preparation
LOD = limit of detection; SPE = solid-phase extraction; SPME = solid-phase microextraction;
CSPE = cartridge solid-phase extraction; MLLE = microliquid liquid extraction; ICECLES = ice
concentration linked with extractive stirrer; HPLC = high-performance liquid chromatography;
MS = mass spectrometry; ESI = electrospray ionization; GC = gas chromatography; CI =
chemical ionization; HR = high resolution; NPD = nitrogen phosphorous detector; NCD =
nitrogen chemiluminesence detector; EI = electron ionization.
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3.3. Material and methods
3.3.1. Materials
All reagents were HPLC grade, unless otherwise stated. N-nitrosodipropylamine,
(NDPA) standard (100 mg neat) was purchased from Sigma–Aldrich (St. Louis, MO,
USA). Isotopic labelled N-nitrosodipropylamine (NDPA-d14, 98%) was obtained from
Cambridge Isotope Laboratories, Inc, (Tewksbury, MA, USA). Isopropanol, (99.5%) was
purchased from Fisher Scientific (Fair Lawn, NJ, USA). Water was purified using a water
PRO PS polisher (Labconco, Kansas City, KS, USA) at a resistivity of 18.2 MΩ cm.
Most water samples were irradiated for at least 26 hours with UV light from a xenon arc
lamp (intensity 350 mW/cm2; Newport light source model 66903) to photodegrade
inherent NDPA. All stock solutions were prepared in de-ionized irradiated water, while
standards and blanks were prepared in irradiated tap water. A stock solution of both
NDPA and NDPA-d14 were prepared as a 1 mM aqueous solution, placed in an amber
bottles and stored at 4ºC, and freezer (-30 °C) respectively, to prevent decomposition of
NDPA and NDPA-d14. Every three weeks, a new working stock solution of NDPA was
prepared, while the working stock solution of NDPA-d14 was thawed immediately prior to
each analysis.
3.3.2. ICECLES Sample Preparation
The apparatus and the general procedure used for ICECLES were reported by
Maslamani et al. [165]. Briefly, the apparatus consisted of five main parts: 1) a
circulating chiller, 2) a double-walled or “jacketed” beaker, 3) magnetic stir plate
(4.25 in × 4.25 in), 4) a sorptive stir bar, and 5) an amber glass sample vial (40 mL). The
ICECLES sample preparation procedure consisted of adding a water sample (10 mL,
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spiked or unspiked water with 200 µL of 1 µg/L of NDPA-d14 internal standard) to a 40
mL glass amber vial along with a PDMS-coated stir bar. The vial was capped and placed
into a double-walled beaker with coolant (-7 ºC) continually circulated. Isopropanol (1
mL) was added to the bottom of the beaker to ensure adequate thermal contact between
the vial and the cooled beaker. The stir bar was stirred at 1200 rpm, and the sample was
allowed to freeze progressively from the bottom until the water was completely frozen.
As the sample froze, the sorptive stir bar remained stirring on the top of the ice. After
extraction, the PDMS stir bar containing the extracted analyte was removed from the vial
using a clean teflon-coated magnet.
3.3.3. Gas Chromatography-Mass Spectrometry
All prepared stir bars were analyzed using an Agilent Technologies 7890A gas
chromatograph and a 5975C inert XL electron ionization (EI)/chemical ionization (CI)
mass selective detector (MSD) with Triple-Axis Detector and a Gerstel Multipurpose
Sampler (MPS). The stir bars were thermally desorbed in a thermal desorption unit
(TDU) in splitless mode, with NDPA trapped in a cooled injection system (CIS). The
initial thermal desorption temperature was 60 °C (held for 0.20 min), increased linearly at
720 °C/min to 250 °C, and then held constant at that temperature for 1.5 min. The analyte
was collected in the CIS at -100 °C, cooled with cryogenic nitrogen. The CIS was then
heated to 250 °C at a rate of 12 °C/s. Subsequently, NDPA was transferred to the GC
column with initial oven temperature of 35 °C. The GC oven temperature was linearly
increased at rate of 20 °C/min until it reached a final temperature of 240 °C. Separation
was achieved by using an HP-5MS capillary column (30 m × 250 μm x 0.25 μm) with
helium carrier gas at a flow rate of 1 mL/min and a column head pressure of 6.5 psi. The
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MS source and quadrupole temperatures were 280 °C and 150 °C, respectively. Electron
ionization was used to fragment the NDPA with a voltage of 70 eV. Acquisition was
carried out using selected ion monitoring (SIM) for ions 70 m/z (identification, [MCH3CH2CH2O]+), and 130 m/z (quantification, [M-H]+) for NDPA and 144 m/z for
NDPA-d14. The quantification ion was selected based on its signal to noise ratio. After
confirmation of the identity of NDPA and NDPA-d14, only 130 and 144 ions respectively,
were used in the final method with a dwell time of 500 ms. Because the analysis of
NDPA was completed at ultratrace levels, the stir bars were conditioned and cleaned with
the TDU conditioner system at 300 ᵒC for 3 hours, then cooled, and the absence of a
NDPA peak in the nonspiked stir bars prior to analysis verified with the method.
3.3.4. Method Validation
For the determination of the limit of detection (LOD), multiple concentrations of
NDPA below the LLOQ were spiked in irradiated drinking water in triplicate and
analyzed by the analytical method. The LOD was determined as the concentration that
reproducibly generated a signal to noise ratio of 3 based on the chromatograms. Noise
was calculated as peak-to-peak noise in the blank (i.e., non-spiked irradiated water only)
over the retention time of NDPA. The linearity of the method was determined by
analyzing NDPA calibration standards in irradiated drinking water with the internal
standard (200 µL of 1 µg/L NDPA-d14) in triplicate at ten different concentrations
ranging from 0.2 to 200 ng/L (i.e., 0.2, 0.5, 1, 2, 5, 10, 20, 50, 100, 200 ng/L). The
average signal ratios were plotted against the corresponding nominal concentrations. The
lower limit of quantification (LLOQ) and the upper limit of quantification (ULOQ) were
selected based on the following inclusion criteria: precision (expressed as the relative
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standard deviation) of <20% and an accuracy of 100±20% as calculated by comparing the
experimental concentration to the nominal concentration of the calibrator. The analyte
concentration was back-calculated from the calibration equation using the average signal
ratio of each calibrator. Inter-and intraassay precision and accuracy were determined by
analyzing low, medium, and high quality control (QC) standards in quintuplicate with
concentrations not included in the calibration curve (i.e., 3.5, 15 and 35 ng/L,
respectively) over three separate days and within ten calendar days.
The stability of NDPA was determined by storing the QC samples (low and high)
at different temperatures. The internal standard was spiked immediately prior to sample
preparation and analysis. In order to correct for run-to-run variability, bench top and
autosampler stability were evaluated at room temperature (RT), while the long-term
stability was determined at 4 °C,−30 °C and −80 °C, all at multiple storage
times/durations. The samples stored at −30 °C, and −80 °C were left to thaw unassisted at
room temperature for analysis. For freeze-thaw stability, three set of QC standards were
stored at -80 °C. All standards were thawed, one set was analyzed, and the rest of the QC
standards were re-frozen at -80 °C. The process was repeated for the remainder of the
freeze-thaw QC samples. Stability of the NDPA at a particular concentration, at any
given storage time and temperature, was calculated as percentage of the initial signal (QC
standards freshly prepared each day of the analysis). The NDPA was considered stable if
the signal from the stored sample was within 10% of the freshly prepared QC standard.
Recovery was determined by analyzing QC standards in tap drinking water
(irradiated), and compared to QC standards of same concentrations in de-ionized water
(irradiated), all in quintuplicate. The recovery was evaluated by dividing the average
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signal of NDPA in irradiated tap water to that in irradiated de-ionized water, and
expressed as a percentage.
3.3.5. Sample Collection Protocol and Analysis of Water samples
Various water samples from different locations, each with different water
treatment facilities, were analyzed to determine NDPA contaminants. Tap water samples
were collected from Brookings (South Dakota), Sioux Falls (South Dakota), and Lake
Hendricks (Minnesota). The samples were collected in pre-cleaned amber vials with
Teflon-lined polyethylene caps to prevent photodecomposition of NAs, if present. The
cleaning protocol for the sample collection container glass vials was similar to that
described by Maslamani et. al., [165]. The amber vials were soaked in water, methanol
and soap for 24 h each, rinsed several times with an NDPA free-deionized (DI) water
(i.e., irradiated DI water that was previously analyzed with the method to confirm the
absence of NDPA), and dried at room temperature [156] for at least 24 h. The vial was
filled with NDPA-free DI water and stored in the refrigerator for 24 h. ICECLES analysis
was performed (in triplicate) to ensure sampling vial cleanliness prior to sampling of the
tap water at the various locations. Samples were collected as follows: 1) the valve of the
water source was fully opened, and allowed to flow at full strength for about 3-5 minutes,
2) the flow was regulated to approximately 50 mL/min, and water was collected into the
requisite container until overflowing, then the vial was capped immediately. The water
was stored for about 5 minutes and dumped. The vial was then re-filled in the same
manner and capped [165]. Samples were added to insulated containers during
transportation. The samples were subsequently stored in the dark in the refrigerator
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(between the temperatures of 4− 6°C) until analysis. Samples collected and stored in the
refrigerator were analyzed within 3 days [147, 149, 204-206].
3.4. Results and Discussion
3.4.1 ICECLES Sample Preparation and GC-MS Analysis
NAs, including NDPA, have relatively low log Kows, ranging from -0.57 to 3.13.
Consequently, they are difficult to extract with organic solvents or common solid
sorbents [16, 17]. Moreover, their Henry’s constants are very small, making it difficult to
isolate them from the sample headspace [16]. Therefore, most methods for ultratrace NA
analysis require very large sample volumes, arduous sample preparation, and
sophisticated instrumentation (as seen in Table 3.2). The recently introduced ICECLES
technique, first reported by Maslamani et al. [165], has demonstrated phenomenal
extraction efficiencies of compounds with relatively low log Kow (<3.0). It is simpler,
greener, and generally requires only a low resolution GC-MS for ultratrace analysis. In
addition, the automated ICECLES procedure is a stark contrast to most SPE, MLLE, and
LLE methods listed in Table 3.2, which require constant attention.
For the method presented here, a PDMS-coated stir bar was added to 10 mL of tap
water and stirred as the sample was frozen. By following the experimental procedure
described in the method section, the stir bar remained spinning on top of the frozen
portion of the sample. After the sample was completely frozen, the stir bar was simply
removed from the top of the sample. NDPA was then desorbed from the stir bar via
thermal desorption and analyzed by a low-resolution GC-MS in electron ionization mode.
Figure 3.1A shows the selected ion chromatograms of the quantification ion for the
analyte and internal standard, both eluting at 5.1 min. The total GC-MS run time,
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including desorption and equilibration, was approximately 15 minutes. The NDPA peak
was sharp but did show some minor tailing (As=1.6). The method showed excellent
selectivity with no interferent peaks in the boiled, irradiated tap water blank. Figure 3.1B
shows the effect of UV irradiation on the tap water, where tap water was analyzed with
the method before and after UV irradiation. The NDPA peak disappeared after the
irradiation with UV light. Since NDPA elutes at 5.1 min (Figure 3.1A) and it is removed
by UV irradiation, the peak in the non-irradiated tap water can likely be attributed to
NDPA contamination of the tap water source.
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Figure 3. 1. Chromatograms of spiked and unspiked NDPA in irradiated tap water. A)
Chromatograms showing the elution time of NDPA (130 m/z) and internal standard
(NDPA-d14, 144 m/z) at 5.1 minutes. B) The effect of irradiating the tap water with
strong UV light led to photodecomposition of NDPA from the tap water. The
disappearance of the peak at 5.1 minutes after UV irradiation indicates a preliminary
confirmation of the presence of NDPA in the tap water (B).
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3.4.2. Limit of detection (LOD), signal enhancement, dynamic range, and sensitivity
The LOD, as measured by a signal-to-noise ratio of 3, was 0.2 ng/L (i.e., 200
ppq). The excellent LOD was due to the efficient extraction of NDPA into the PDMS stir
bar during ICECLES. This LOD was produced via analysis with a low resolution GCMS, only 10 mL of sample, and automated sample preparation, in contrast to methods
using more sophisticated instrumentation (i.e., GC-MS-MS or LC-MS-MS), larger
sample volumes (250-1000 mL), longer sample preparation times, and sample
preparation requiring constant attention (Table 3.2). The only method we found which
utilizes a low resolution GC-MS, You [151] in Table 3.2, did produce an LOD similar to
ICECLES (0.332 ng/L), but required 500 mL of sample, about 6 hours of sample
preparation, and constant attention during addition of the sample to the SPE cartridge
during sample preparation.
Theoretically, the fraction of analyte extracted (fextr) via ICECLES is governed by
Equation 3.1, assuming complete freezing of the sample [207]. Kice represents the
equilibrium constant between the liquid and solid sample matrix. The Vice and VSB are the
final volumes of the ice and the PDMS, respectively. Using the volumes in this study, a
typical Kice of 10-3, and estimating KSB ≈ Kow of NDPA (i.e.,Kow is a good estimate of
KSB, the distribution constant of the analyte between an aqueous phase and the stir bar),
the amount of NDPA expected to be extracted into the PDMS is 99.9%. Because of their
similarities, the performance of ICECLES relative to SBSE was also evaluated. The
combined FC and SBSE extraction of analytes via ICECLES made it possible to
efficiently extract NDPA (log Kow = 1.36) from drinking water, producing a signal
enhancement of 198 versus room-temperature SBSE.
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𝑓𝑒𝑥𝑡𝑟 =

𝐾𝑆𝐵 𝑉𝑆𝐵

(3.1)

𝐾𝑖𝑐𝑒𝑉𝑖𝑐𝑒 +𝐾𝑆𝐵 𝑉𝑆𝐵

The linear range for the current method was 2 to 50 ng/L using a weighted 1/x2
fitting linear regression. Because the MRL of NDPA is within the linear range, this
method is well-suited for the evaluation of NDPA contamination in drinking water. The
calibrator concentrations of 0.2, 0.5, 1, 100 and 200 ng/L were evaluated but did not fit
the accuracy and precision criteria. The regression equations, correlation coefficients
(R2), and the Percent Residual Accuracies (PRAs) [188] for the 3-day validation study are
outlined in Table 3.3. The PRA values for all the calibration curves generated for the 3day validation process was ≥90% (Table 3.3), indicating a good fit over the entire linear
range [188]. In addition, the precision and the accuracy of calibration curves were
acceptable (Table 3.4) [208].

Table 3. 3. Regression models, R2 and PRA values for separate calibration curves over a
3-day period.

a

Days

Equation for line

R2

PRA

Day 1

y = 0.0117x+0.0139

0.9887

90.77

Day 2

y = 0.0172x+0.0346

0.9959

91.12

Day 3

y = 0.0174x+0.0715

0.9948

90.25

Equation in the form of y = mx + b, where x = NDPA concentration (ng/L) and y =
signal ratio for the peak area abundance of the 130 /144 m/z ions from the GC-MS
chromatogram.
b
Percent Residual Accuracy [188].
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3.4.3. Method Validation: Inter-assay and Intra-assay Precision and Accuracy
The intra- and interassay precision and accuracy, determined by quintuplicate
analysis of the QC standards (i.e., low, medium, and high) over ten calendar days, are
shown in Table 3.4. The intra- and interassay precision of the NDPA in drinking water
was <13% RSD, while the intra- and interassay accuracy was 100±17.5%.

Table 3. 4. Intra-and Interassay accuracy and precision for ICECLES analysis for NDPA
in drinking water.
Nominal

Intraassay

Intraassay

Interassay

Interassay

Conc.
(ng/L)

Accuracya
(%)

Precisiona
(%)

Accuracyb (%)

Precisionb (%)

3.5

100±3

<12

100±14

<12.5

15

100±9

<8

100±5

<11

35

100±17.5

<10

100±8

<12

a

QC method validation for Day 1 (N=5), b Average QCs for 3 different days of
validation (N=15)

3.4.4. Matrix effect and recovery
Matrix effect analysis provides an estimation of signal attenuation or
enhancement that may lead to loss or gain in signal of the analyte. The matrix effect was
estimated by comparing the slope of a calibration curve produced in irradiated tap water
to that in irradiated-deionized water (i.e., slopetap water/ slopeDI water). The slope ratio was
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0.83, which is suggestive of a slight matrix effect, most likely be due to ion suppression
in the irradiated tap water. The matrix effect for the internal standard correctedcalibration curve in both tap water (irradiated) and de-ionized was 1.02, indicating that
the IS was effective at correcting for any variations in signals of the analyte.
The recoveries for NDPA for low, medium, and high QCs, were 93.2, 101.3,
85.3%, respectively. These recoveries were excellent. The relatively low recovery for the
high QC could be due to saturation effect and/or matrix/suppression effects.
3.4.5. NDPA Stability
Bench top stability for the NDPA was evaluated for the low (3.5 ng/L) and high
QC (35 ng/L) in irradiated tap water at 0, 2, 4, 8, 12 and 24 hrs. Thus, the samples were
left on the bench top for the desired time, spiked with fresh IS and analyzed by
ICECLES-GC-MS. NDPA (without inclusion of IS for the signal ratio) was stable up to 2
hours (105% recovered) and began to degrade after 4 hours (88% recovered). When the
signal ratio was considered, the IS corrected for low and high QCs for the 24-h period
(i.e., signal ratios were between 100 and 108% of the original signal ratio). It is important
to note that the samples were reasonably protected from light (i.e., stored in an insulated
foam container made of thick polystyrene) while standing on the benchtop and when
placed on the GC-MS auto-sampler (i.e., all lights were turned off during the analysis
with GC-MS).
Similarly, the autosampler stability was tested for 0, 2, 4, 8, 12, and 24 hours. The
noncorrected low QC signal was not stable at any time tested within 2 hours but the high
QC was stable up to 4 hours (Figure 3.2A). When using IS to correct for loss of signal,
the signal ratio was stable for the 24-h period (Figure 3.2B).
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The low QC NDPA was stable at 4 °C for 15 days, while high QC was stable for
30 days. With IS correction, all QC signal ratios were stable for at least 30 days. Stability
at -30 and -80 °C for both low and high QCs was stable for 30 days with and without the
IS correction following storage.
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Figure 3. 2. Determination of auto-sampler stability, and the ability of the IS to correct
for signal loss at room temperature. (A) NDPA signal stability plotted without IS (B) IS
corrected plot of NDPA signal that shows the IS corrects for instability of the analyte
over the 24-hr period at room temperature. Signal loss of the uncorrected NDPA could be
due to thermal or photo degradation on the autosampler.

3.4.6. Analysis of Drinking Water for NDPA
Drinking water samples from various locations in South Dakota (Brookings and
Sioux Falls) and Minnesota (Hendricks) were obtained and analyzed with the method
presented here. The samples were collected in amber vials, stored in pre-cleaned 1-L
amber bottles in a refrigerator, and analyzed within three days of sampling. Figure 3.3
below shows the chromatograms of NDPA spiked tap water (positive control) and
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unspiked tap water sampled from Brookings. The peak at 5.1 min in the drinking water
sample elutes at the same time as the spiked NDPA. Moreover, the NDPA peak
disappeared when the sampled water was boiled and irradiated (similar to Figure 3.1B).
The level of NDPA of the drinking water sampled from Brookings (SD) was 2.38±0.34
ng/L. This concentration of NDPA was below the USEPA MRL. NDPA in the water
samples from Sioux Falls (SD) and Hendricks (MN) was above the LOD but below the
LLOQ for the method (i.e., signals were above the LOD of 0.2 ng/L but not within the
linear range of the calibration curve).
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Figure 3. 3. Chromatograms showing NDPA- spiked tap water (red), and that from
unspiked tap water (blue) sampled in South Dakota on 02/07/2018.The concentration of
NDPA in the unspiked tap water was between 2.04 and 2.72 ng/L at a 95% confidence
limit.

3.5. Conclusion and Future Directions
A quick, flexible, simple, green, and relatively inexpensive method for NDPA
analysis was developed using ICECLES sample preparation coupled with low resolution
EI-GC-MS. This method could be expanded to more NAs (Table 3.1), or simply used for
NDPA analysis. The use of GC-CI-MS may allow more selectivity for the NAs in Table
3.1 and should be used as a strategy for a more comprehensive method for NAs. That
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said, because NAs are typically found together, NDPA may be able to act as a probe
molecule for screening drinking water. Therefore, this method could potentially be used
to screen drinking water for NDPA, with follow-on analysis via more comprehensive
method (see Table 3.2) if NDPA concentrations in the drinking water source are
concerning. The figures of merit were within USEPA guidelines, and the usefulness of
the method was verified by detecting NDPA in drinking water samples.
1.14.
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CHAPTER 4. BROADER IMPACTS, CONCLUSION AND FUTURE
DIRECTIONS
4.1. Broader Impacts
Currently, there are some limitations with the available cyanide antidotes, such as
slow onset of action, administration requiring supportive care and trained individuals, and
limited applicability to mass casualty situations. From recent studies, Cobinamide (Cbi)
has shown excellent potential as a cyanide antidote. In order for the FDA to approve Cbi
as an antidote, there is a need to conduct a comprehensive pharmacokinetic studies for
the drug (Cbi). This includes in-vivo determination of the “available” and “total” Cbi in
biological fluids. Therefore, a bioanalytical technique to differentiate available Cbi from
total Cbi is vital to help the translation towards FDA approval. Consequently, the LCMS-MS method developed in this study should provide tremendous information for the
advancement of this Cbi as cyanide antidote. Moreover, the data obtained from this study,
definitely verified in-vivo the hypothesized mechanism of treatment of Cbi for cyanide
poisoning (via direct binding of cyanide).
Since nitrosomaines (NAs) are produced as disinfection byproducts, and are
probable cause of cancer, it is very important to test treated water prior to delivery to
consumers. Current methods available for NA analysis require sophisticated and
expensive instrumentation and arduous sample preparation, some requiring hazardous
organic. This makes monitoring of these probable carcinogenic compounds at trace levels
in drinking water quite difficult and expensive, which limits many municipalities from
monitoring drinking water. Therefore, a relatively inexpensive method that utilizes a low
resolution and inexpensive gas chromatographic instrumentation coupled with flexible,
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automated, and greener sample preparation technique should enable monitoring of NAs at
trace levels (i.e., MRLs) as stipulated by the USEPA. This would allow increased
monitoring and potentially help prevent development of cancer based on NA exposure
through drinking water consumption. The analytical method, ICECLES-GC-EI-MS,
reported here affords a solution to the challenges associated with the current method for
analysis of NAs at trace levels.
Overall, the methods presented in this dissertation should help facilitate
development of Cbi as a countermeasure for cyanide (which has ubiquitous sources) and
facile and prompt screening of NAs in drinking water to help decrease exposure to NAS.
4.2. Conclusions
The methods presented in this dissertation have significant impacts for the
approval of Cbi as cyanide antidote, and regulation of NAs in trace amounts. We have
shown systematically how to deal with a much known problem of residual Cbi by
developing a comprehensive how a cleaning protocol. For the first time, we have
developed a method that can be utilized to help in the classification and regulation of
nitrosoamines.
The LC-MS-MS method developed was able to analyze available Cbi, and was
used to verify in vivo for the first time, the hypothesized mechanism of Cbi as cyanidebinding agent, making it possible for more detailed pharmacokinetic studies of Cbi to be
conducted, and ultimate approval by the FDA as cyanide therapeutic.
The ICECLES sample preparation coupled with low resolution GC-EI-MS
method reported here allows for trace analysis of NDPA, as required by the USEPA.
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This method eliminates some of the challenges of current methods for NAs analysis, and
helps reduce the risk of cancer associated with NAs in drinking water.
4.3. Future Work
Ideal cyanide antidotes are very critical in reversing cyanide poisoning in a timely
fashion. Consequently, the use of the presented method to evaluate CyanoCbi, total Cbi,
and available Cbi for comprehensive PK studies that facilitate the determination of a
detailed pharmacokinetic behavior of Cbi, which will help facilitate the approval of Cbi
as cyanide antidote. The future work will address this aspect of the research.
The ICECLES-GC-EI-MS method should be extended to analyze more NAs in
the future. Specifically, ICECLES sample preparation coupled with low resolution GCCI-MS may produce very sensitive and selective method for analysis of NAs [209]. The
ultratrace analysis of other NAs with ICECLES-GC-CI-MS would be explored.
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